Medical Evaluation and Treatment of Patients with
Chemical Injury and Sensitivity
by
Grace Ziem,
M.D., Dr. P.H.,
Conference Sponsored
by the
National Institute of Environmental Health Sciences
August 13-15, 2001
Medical Evaluation and Treatment of Patients with Chemical Injury and Sensitivity
Abstract
Medical testing was conducted on 30 consecutive toxic injury new patients seen in the author’s medical practice. These patients typically had toxic encephalophathy with reactive airways disease. Other abnormalities were quantified by testing, and included adrenal cortisol changes with frequent deficiency; protein deficiency with greatest deficiency in detoxification-related amino acids; changes in Phase II detoxification following challenge, with deficiency of glutathione and superoxide dismutase and increase of lipid peroxides and other free radicals; changes in cell membrane lipid composition to a proinflammatory status; Secretory IgA deficiency with frequent parasites and/or Candida; pancreatic digestive enzyme (chymotrypsin) deficiency; food intolerances; intracellular essential mineral deficiency; reduced antioxidant function; altered energy metabolism; and other nutrient defiency, the most prevalent being B12 (involved with myelin synthesis). Toxic exposures inducing illness were symptomatic (and repeated, except one patient from a massive propane leak). Other causal agents were solvents, pesticides (organophosphates, pyrethroid, chlordane, benzyl benzoate, other), vehicle exhaust in a building, “sick building” volatiles, adhesives, inorganic chlorines, formaldehyde and glutaraldehyde.
Introduction
Toxic
exposure to a variety of petrochemical compounds or combustion products can
induce permanent heightened intolerance to chemicals.[1]
Toxic induced brain damage, also called toxic encephalopathy, can also
induce chemical intolerance.[2],[3] Even
relatively short term exposure to petrochemical compounds can cause a
significant heightened intolerance to future chemical exposures.3 Short-term intermittent exposures at even
modest levels are capable of causing heightened neural (brain) sensitization by
means of the mechanism of time dependent sensitization.[4],[5]
Toxic
Encephalopathy
Many petrochemical
compounds have been shown to cause chronic changes in brain function as
documented by testing.[6],[7],[8],[9],[10],[11],[12],[13],[14]
Industrial accidents and exposures, sick building exposure and
environmental overexposure's are all capable of causing toxic encephalopathy.[15]
Persisting brain damage can be caused by either repeated or single acute
symptomatic exposure to combustion products, pesticides, volatile organic
compounds, solvents, inorganic and organic chlorines, hydrogen sulfide, and a
wide range of petrochemicals.15,[16],[17],[18] Even
low-level exposure to volatile petrochemical compounds can cause changes in
brain function.[19]
Short-term exposure can also cause toxic encephalopathy.3 Numerous studies document toxic
encephalopathy resulting from low level chronic exposure.[20],[21],[22],[23]
Further exposure after brain damage begins causes additional damage,[24] demonstrating the need for early detection
and focusing on neurologic symptoms with exposure at an early stage, such as
impaired attention span, reduced memory and/or concentration, headache, balance
disturbance or impaired coordination, because these can become permanent10,11,13,14,[25],[26] unless the individual is removed from
exposure and/or the exposures promptly controlled to below a symptomatic level.
Because petrochemical
compounds are often lipid soluble, they are readily taken up into the brain and
concentrate in the lipid part of the brain.[27]
Toxic compounds are also capable of entering the brain directly through
the nose.[28],[29] The
brain also has a special vulnerability to toxic damage because of other
factors, including the long shape of nerve cells and the high metabolic rate of
the brain so that even minutes of adverse changes in brain metabolism can cause
brain cell death.28 The
relatively small number of neurons which utilize the neurotransmitters dopamine
or acetylcholine creates increased
vulnerability to causing, respectively, profound reductions in coordination and
memory.28 Further, brain cells are unable to regenerate, so that
death of a brain cell is usually permanent.28 Impairment of energy metabolism increases
the risk of brain and nerve cell damage.28 Such impairment is
common.[30]
Impaired energy metabolism is found in the vast majority of chronically
ill toxic injury
patients.30 Petrochemicals are also able to attack the
membranes of nerve cells, causing damage.[31]
SPECT brain
scans on individuals with chronic symptoms following toxic exposure to various
petrochemical compounds compared to healthy control subjects show reduced blood
flow to the brain and reduced ability of the brain to take up the tracer
substance in the early phase of injection.[32],[33],[34] This
is often not evident in the late phase of injection with SPECT scan testing,
emphasizing the need for such scanning to focus on the early phase of
injection, which is not always done when this scanning is performed for
evaluation of other neurologic conditions.
Changes seen in these SPECT brain scans studies involve the frontal,
temporal and limbic brain areas.
Because of the well known relationship of the limbic brain to emotions,
those lacking thorough knowledge of toxic encephalopathy can confuse
toxic-induced brain effects with a psychologic condition. However, mood and personality changes which
are long-standing have been documented in patients with toxic encephalopathy.10,11,13,14,25,26 A study which evaluated symptoms in toxic
encephalopathy patients secondary to long-term exposure to organic solvents
found chronic persisting symptoms of fatigue (90%), impaired short-term memory
(94%), reduced concentration (88%), irritability (84%), headaches (81%) and
other neuropsychiatric effects.17
Reactive
Airways
Another
mechanism by which toxic injury can cause heightened future sensitivity to
chemical exposure is reactive airway disease.
Repeated modest or even "tolerable" level exposure to
irritants,[35],[36] higher dose single36 or repeated[37] exposure to irritants can cause permanent
reactive airway disease. This induces
significant increased respiratory sensitivity to irritant exposures in the
future.35,37 Irritants cause
reactive airway disease of upper and/or lower airways by release of the
inflammatory substance P and the mechanism called neurogenic inflammation.[38]
Biopsy study has confirmed that irritant exposure can cause loss of the
protective nasal epithelial cells, increased permeability (which could allow
future irritants to enter more readily),
chronic
inflammatory changes, and an increase in the number of nerve
fiber endings
of the olfactory nerve in the nose.[39] These
changes would not only affect the respiratory system but would increase the
risk of toxins entering the brain directly through the nose. Other scientists have independently
confirmed that reactive airway disease can involve the upper as well as the lower
airways.[40]
Reactive
airway disease can be induced by volatile organic compounds.[41]
These compounds as well as virtually all other petrochemicals are
irritants[42],[43] Non petrochemicals such as ammonia and
chlorine[44],[45] are also irritants. Reactive airway disease can be induced by
solvents,39 pesticides,39
indoor air pollutants,[46] and inorganic irritants.39,14
Reactive airway disease is considered a long-standing or permanent phenomenon
even after the initial causal exposure has been discontinued.[47],[48],[49]
Respiratory
irritation in humans at even low levels of exposure to a mixture of irritants
and/or volatile chemicals shows more than additive effect.44,45 The degree of hyperadditivity increases with
the number of substances present and also with the fat soluability of the
chemicals.41 Prior irritant
exposure increases the irritant effect of subsequent irritant exposure.44 Longer duration of low level exposures
and/or higher levels of chemical mixtures increases both adverse response of
symptoms as well as sensitization.[50] A
key feature of reactive airway disease is heightened respiratory symptoms with
exposure to irritants.35,36,37,41
Nonrespiratory symptoms are also increased following irritant exposure
with reactive airway disease,41 which is consistent with the
inflammatory response and release of inflammatory substances (which increase
fatigue, aching, etc.) as well as the reduction of the protective nasal
epithelium and thus increased ability for toxins to enter the brain.
Intolerance
to chemical irritants has also been reported in persons with asthma39,[51] and in those with rhinitis.39 Additionally, a community based
epidemiologic study of individuals diagnosed with asthma found a higher level
of illness exacerbation from irritants such as new carpets, scented products
and cleaning products compared to nonasthmatics.[52]
Persons with a diagnosis of hay fever also experience frequent illness
exacerbation from irritants such as pesticides and vehicle exhaust.42
Asthmatics and individuals with hay fever also have significant exacerbation
from irritants such as drying paint and passive smoke.42
A study of
non smoking individuals with reactive airway disease/airway hyperreactivity to
irritants showed that testing such as methacholine challenge, chest x-rays and
lung function tests were not reliable predictors of reactivity, that symptoms
typically involved the upper and lower airways and often failed to respond to
(beta 2 agonist) bronchodilators or steroids, and were commonly accompanied by
symptoms such as fatigue, headache and/or musculoskeletal aching.[53] When
these patients were challenged tested, the authors found that the hyper
reactivity involved not only the upper and lower airways but also the
eyes. Perfume challenge testing below
the smell level exacerbated symptoms of airway hyperreactivity in the upper and
lower respiratory tract as well as causing headache and fatigue.50,[54]
This challenge testing also exacerbated eye symptoms. Psychologic causation was ruled out.50,54 Eye irritation also occurs with irritant
exposure at even low levels, and with mixtures of irritants shows more than
additive effect on eye irritation in humans.41
Evaluation
of Chemical Exposure
The author has
long been a treating physician for hundreds of toxic injury patients. This paper reflects that experiences as well
as the medical literature.
A basic
principle of toxicology is that lowering exposure reduces the risk of adverse
health effects.[55] When
determining what exposure controls are most appropriate to a particular
patient, it is useful to evaluate whether they have toxic related organ changes
(see discussion below) and their response to commonly encountered exposures to
irritants and other toxins. A
questionnaire which is excellent for characterizing the dose response
relationship of a particular individual for exacerbating exposures was
developed at the Johns Hopkins School
of Hygiene
and Public Health by Dr. Davidoff and colleagues and has
been validated in
the peer-review medical literature.[56] The author has used this questionnaire1
for many years in evaluation of toxic injury patients because it describes the
duration of exposure, characterizes an exposure in readily understandable
language that helps to assess its intensity, and characterizes the response. It
is also useful to ask the question:
“how long does it usually take to feel as good as you did before” to assess
recovery time from exacerbations. Another useful assessment instrument which
the author has utilized was developed by Dr. Kipen and colleagues[57] (Appendix I). This assessment instrument is particularly useful to determine
which specific exposures and products are problematic in the home, school or
workplace.
Careful
evaluation of the home environment is important because of the amount of time
individuals spend in the home. The
author utilizes a home questionnaire section (Appendix II) and reviews the responses with the patient, obtaining
further information as indicated. It
has been the author’s consistent experience that individuals who have chemical
exposures in their community sufficient to exacerbate symptoms on a recurring
basis experience significant health improvement by relocating unless the
community exposure can be controlled below levels which exacerbate symptoms,
eg., when opening windows, being outside near the home.
If the
individual is working or attending school, it is important to evaluate whether
the workplace or school has exposures which exacerbate symptoms. For occupational exposures, many principles
of an occupational exposure history apply.
These include the timing of symptoms relative to exposure, such as
whether the individual is more symptomatic at home or at work, particularly
early in the course of illness. For
individuals who have become chronically ill, significant improvement may not
occur with being away from exposure for only hours or a few days, so for these
individuals information about symptom levels when the individual is away for
longer periods of time such as several weeks or more is particularly
helpful. It is useful to obtain
information about the tasks being performed, with sufficient detail to allow a
mental image of the exposure in relation to the individual. Asking the person to provide a diagram is
also a helpful aid in clarifying the exposure.
Material safety data sheets or other means of obtaining the chemical
identity of exposures is useful, and the health care provider can obtain this
information with the patient’s consent through the OSHA Hazard Communication
Standard: 29 CFR 1910.1200. Results
from workplace medical monitoring can be obtained through the OSHA Access to
Medical Records provision: 29 CFR 1910.0020.
This allows the health provider or other designated representative, with
the patient’s consent, access to any workplace study and personal and/or
medical monitoring for which the employer has a copy, thus allowing access for
information conducted by consultants as well as in-house studies. Information about the heating, ventilation
and air-conditioning (HVAC) system is also useful. Exposure is more likely to affect the individual in work areas
that share a common air supply through the air handling system. Air monitoring, HVAC studies etc. are often
done after some corrective measures have been taken: this makes them
nonrepresentative of original exposures.
Common use areas such as entryways, hallways, meeting rooms and
restrooms should also be evaluated.
Similar principles apply to the school environment, although students,
unlike teachers and other school employees, do not have OSHA protection
regarding information access. It
is often possible to obtain needed
exposure information through the individual and/or school administration.
Exposure
Control
It is been
the author’s consistent experience with toxic-induced chronic illness that the
most significant factor for future health is the extent to which exposures can
be controlled below symptomatic levels. There are four studies in the medical
literature which confirm that reduced exposure is the major factor in the
long-term outcome of patients who have developed chemical intolerance: Dr. Lax,[58] an occupational medicine physician, found
that his patients who had environmental controls did much better than patients
without adequate environmental controls.
A survey of 305 persons with chemical sensitivity by DePaul University[59] found that they experienced much greater
relief from environmental controls and reducing exposure than with any other
form of treatment, and that the use of tranquilizing agents was actually less
effective than meditation or prayer.
Another study by Dr. Jason[60] found that individuals were chemically
sensitive and had relatively nontoxic housing had much better long term health
than those that did not have adequate environmental controls in their
housing. This is because once chemical
sensitivity is induced, it can be exacerbated by exposures at work, at home, or
elsewhere. A fourth study of 206
chemically hypersensitive patients by Dr. Miller and colleagues[61] found that reducing exposure to chemicals
was very helpful for 71%, but only 17% of the patients who used psychological
or psychiatric services/treatment found those to be very helpful. It is
important to focus on exposure control in the environments where the person
spends the most time: work, school, and home.
Current
occupational exposure limits (TLVs) have shown no statistical correlation with
health effects.[62]
Adverse health effects are often reported in the medical literature
below these exposure limits.[63] Thus
they are often not a reliable guide of the health status of a working
environment even for workers without toxic injury, and are thus likely to be
less protective for workers who have already developed work-related symptoms.
Accomodation
If the individual has symptoms with a medical condition which
significantly interferes with major life activities, they can be considered to
have a qualifying condition under various disability legislation and
regulations. The most effective
approach is to discuss with the individual the exposure situations, utilize
knowledge of the health care provider and/or other information sources, and
then formulate a request for reasonable accommodation which is planned
according to the types of exposures and the degree of severity of the
exacerbated response, also taking into consideration the known toxic properties
of the substance(s).
Nontoxic and
least toxic pest control methods have been developed for virtually all weeds
and pests,[64],[65] and should be requested for persons with any
disabling symptoms or symptoms which are exacerbated in that environment and/or
frequent symptoms. It is the author’s
experience that pesticide residue, even when weeks old, can exacerbate illness
in individuals who have toxic-induced illness and/or heightened intolerance to
pesticide residue by history. The
reasonable accommodation provision regarding nontoxic pest control would
probably not apply to agricultural situations in which the crop is an important
source of livelihood, but advance notification can then be utilized. This provides much less protection but still
allows the individual to take some preventive precautions as described below. In the author’s experience, chronically ill
persons near agricultural pesticide use have significant difficulty achieving
significant improvement, despite other medical interventions (which can slow or
limit deterioration).
Reasonable
accommodation can also be requested and provided for cleaning agents, air
fresheners and less toxic renovation and repair products. These also have alternatives which are
effective and far less likely to exacerbate symptoms.[66]
Individuals
can also be requested to refrain from the use of scented products if they are
in an environment sufficiently close to an affected individual to exacerbate
symptoms. Because scented product use
is often a personal behavior, compliance is often much more successful if
persons understand the nature of scented products (Appendix III). Illness
reactions in the general population are common to scented products, involving
20 percent or more of the population.[67],[68] Illness reactions can cause migraine
headaches, sinus congestion, hoarseness and/or asthma reactions. Further, scented products residue can cling
to hair and clothing for many hours at levels sufficient to exacerbate illness
hours later. Like the issue of smoking and passive smoke, altering personal
habits may initially be resisted by some individuals, but in the author’s
experience, when users have adequate knowledge and when decision makers set a
positive example and tone, reasonable accommodation can often be achieved.
Other
reasonable accommodations for the workplace can include
changes in
work schedule to reduce exposure to rush hour traffic; and for all
environments, conducting the activity in an area with a window that can be
opened if the exterior environment is less polluted than the interior
environment. Advance notification is also needed for painting or pest control
procedures, since even less toxic products may cause a problem, albeit of less
severity, for certain individuals.
Flexi-place accommodations can be used for home, work and school
environments and are medically necessary if the individual’s health declines or
symptoms aggravated despite attempts to achieve reasonable accommodation or if
adequate accommodation is not achievable or not undertaken.
Once the affected individual and their health care provider and/or other information sources have adequately discussed which accommodations are needed and appropriate, a recommended format is that the individual request in writing the accommodations and the health care provider confirms the meme if the individual’s health declines or symptoms aggravated despite attempts to achieve reasonable accommodation or if adequate accommodation is not achievable or not undertaken.
Once the affected
individual and their health care provider and/or other information sources have
adequately discussed which accommodations are needed and appropriate, a
recommended format is that the individual request in writing the accommodations
and the health care provider confirms the meecision makers set a positive
example and tone, reasonable accommodation can often be achieved.
Other
reasonable accommodations for the workplace can include
changes in
work schedule to reduce exposure to rush hour traffic; and for all
environments, conducting the activity in an area with a window that can be
opened if the exterior environment is less polluted than the interior
environment. Advance notification is also needed for painting or pest control
procedures, since even less toxic products may cause a problem, albeit of less
severity, for certain individuals.
Flexi-place Patients who experience exacerbation
of symptoms in traffic should utilize an automobile activated charcoal
filter. Devices which generate ions are
not medically recommended because of their ability to create airway irritants.
Care should
be taken in recommending specific filtration devices. Areas with a moisture problem should utilize a device with a HEPA
filter, since this is needed to capture mold particles. When mold is not a problem, HEPA filters may
be unnecessary and some HEPA filters can create some exacerbation in certain
individuals because of their glues. Consideration should be given to the noise level of the device to reduce the risk
of gradual hearing loss. Whole house filtration can also reduce noise if
properly located. The device also needs to be adequate for the space and
contaminant level. Thus for workplaces
it is often useful to use a smaller office.
For the home, it is helpful to have such filtration at least in the
individual’s bedroom and major living areas.
In many environments it is more effective to leave the filter device
running so that pollutants do not build up in the individual’s absence. This also avoids the need to turn the device
on high, creating a higher noise level during occupant use.
Some
individuals experience symptom exacerbation from water which is used for
cooking, drinking or shower. This is
more common for chlorinated water, since chlorine reacts with organic debris to
form chloroform. Individuals with wells
near areas of pesticide application also need activated charcoal filtration for
shower/bathing and may wish to consider bottled spring water for drinking and
cooking. Chronically affected
individuals can benefit from whole house activated charcoal water filtration to
control chloroform, pesticides etc., which can be used with backup activated
charcoal filters on shower and cooking/drinking water for optimal control. The investment in filtration devices may
well be offset by a reduction in medical expense and disability. Periodic filter changes are needed, with
frequency according to contaminant levels
and illness severity.
Home Controls
If relocation
is needed or if the individual plans to move, a relatively
nontoxic
house with electric heat and appliances is recommended. Other important features include relatively
nontoxic flooring such as hardwood or tile, a substantial buffer of land,
ideally wooded or a body of water, location preferably not closer than one mile
from agricultural pesticide use, not closer than one-quarter mile from a major
highway, and not close enough to an industrial or other commercial emission
source to notice any detectable odor or particulate. Ideally the house should be free standing and under the control
of the patient, because of the problem of chemical use in an apartment or
condominium. If the house has an
attached garage, an impermeable barrier between the garage and house is
recommended. Windows that open easily in the bedroom, kitchen and other major
living areas are important. Ceiling
fans can be utilized to help reduce the need to close the house during much of
the summer. Very major improvement in health occurs with such housing in the
author’s experience.
Because of
the amount of time spent in the bedroom, often about 60 hours per week, extra
caution in bedroom exposures typically results in reduced respiratory
irritation, fatigue, neurologic symptoms, etc.. Controls here, especially for
individuals with frequent symptoms, are recommended to include mattresses or
futons without petrochemical flame retardants (which may require a physician’s
prescription) and without pesticides, which are common in mattresses as mold
control agents. Mold can be controlled
with a very tightly woven mattress and pillow enclosure called barrier
cloth. Because cotton is often grown using
a significant amount of pesticides, bedding and mattresses using cotton grown
without pesticides often results in reduced symptoms. Because pillows are close to the breathing zone for many hours
daily, even small amounts of offgassing from a pillow can exacerbate
respiratory symptoms, and affected individuals typically improve noticeably
when synthetic pillows are replaced with those containing natural fibers. Patients report that wool containing pillows
are more comfortable than those with cotton. If down is utilized, barrier cloth is essential as is ensuring
that the individual does not have allergies. New onset allergies are not
uncommon in chronically affected individuals and down pillows could potentially
initiate allergy to dander, especially if used without a barrier cloth pillow
case.
Individuals
who experience respiratory congestion with newsprint can utilize a reading box
with proper ventilation to reduce illness exacerbation. Non-toxic airtight
containers to store printed matter in the house reduces exposure. Some affected individuals experience skin
irritation with synthetic clothing and need to utilize clothing made from
natural fibers. Storage of food in containers
made from glass, metal, or wood derived cellophane can reduce food contamination.
Individuals with frequent symptoms following toxic exposure improve when eating
foods not grown with pesticides. This
avoids the ingestion of pesticide residue, which the body must detoxify.
The author
does not recommend or urge affected individuals to remain housebound. Human beings are social beings and have a
need for personal interaction. Some
individuals are so severely affected that until their body can detoxify better,
they will voluntarily choose to limit their social excursions, and should not
be coerced out. Social interaction can
be improved by the use of a proper car filter, by educating friends and social
contacts regarding medical needs, and of course when society implements
reasonable accommodation in public places, such as least toxic pest control,
cleaning agents, and eliminating “air fresheners” from public places,
particularly since these are often odor masking agents and commonly contain
irritants and/or toxins.
Medical
Measures
As an added
measure but not a substitute for exposure control, individuals who experience
symptom exacerbation with an exposure can take measures to reduce intensity and
severity of exacerbations. The author provides a factsheet to patients
(Appendix IV) describing actions they
can take. Due to difficulty with memory in toxic injury, written information is
especially important. Micellized agents
are useful because of the reduced pancreatic enzymes commonly present.30
It is common during significant exacerbations for the body to become more
acidic. pH strips to self test urine
can be used to determine whether this occurs.
Such patients experience improved symptoms with a bisalt or trisalt
mixture, such as two parts of sodium bicarbonate to one part of potassium
bicarbonate (a drop in potassium levels is also common and determining
potassium levels during exacerbation is useful to assess whether this
occurs). Patients who experience
neurologic, respiratory or cardiovascular symptoms during exacerbations often
benefit from oxygen at 3-4 liters per minute using a ceramic mask and Tygon
2075 tubing (to reduce exposure to plasticizing chemicals) until significant
symptom improvement occurs. Body
temperature can drop further; a well tolerated way to assist this is a yutampo
(metal “hot water bottle” in quilted cotton sack.[69] It
should be filled from tap water, not water heated on the stove, to avoid burns.
The author
also recommends a baseline daily broad range antioxidant protection, often 1-11 gm of buffered C powder in water, vitamin E
at 300-400 IU, micellized A at 5,000 IU, and broad spectrum bioflavinoids. Improved pH can be achieved by testing and
dietary information on foods (Appendix V).
Glutathione
The proper
use of glutathione can significantly reduce the severity of exacerbations in the
author’s experience. Glutathione is the
most important intracellular antioxidant in the body. It is ier cloth pillow case.
Individuals
who experience respiratory congestion with newsprint can utilize a reading box
with proper ventilation to reduce illness exacerbation. Non-toxic airtight
containers to store printed matter in the house reduces exposure. Some affected individuals experience skin
irritation with synthetic clothing and need to utilize clothing made from
natural fibers. Storage of food in
containers made from glass, metal, or wood derived cellophane can reduce food
contamination. Individuals with frequent symptoms following toxic exposure
improve when eating foods not grown with pesticides. This avoids the ingestion of pesticide residue, which the body
must detoxify.
The author
does not recommend or urge affected individuals to remain housebound. Human beings are social beings and have a
need for personal interaction. Some
individuals are so severely affected that until their body can detoxify better,
they will voluntarily choose to limit their social excursions, and should not
be coerced out. Social interaction can
be improved by the use of a proper car filter, by educating friends and social contacts
regarding medical needs, and of course when society implements reasonable
accommodation in public places, such as least toxic pest control, cleaning
agents, and eliminating “air fresheners” from public places, particularly since
these are often odor masking agents and commonly contain irritants and/or
toxins.
As an added
measure but not a substitute for exposure control, individuals who experience
symptom exacerbation with an exposure can take measures to reduce intensity and
severity of exacerbations. The author provides a factsheet to patients
(Appendix IV) describing actions they can take. Due to difficulty with memory
in toxic injury, written information is especially important. Micellized agents are useful because of the
reduced pancreatic enzymes commonly present.30 It is common during significant
exacerbations for the body to become more acidic. pH strips to self test urine can be used to determine whether
this occurs. Such patients experience
improved symptoms with a bisalt or trisalt mixture, such as two parts of
sodium bicarbonate to one part of potassium bicarbonate (a drop in
potassium levels is also common and determining potassium levels during
exacerbation is useful to assess whether this occurs). Patients who experience neurologic,
respiratory or cardiovascular symptoms during exacerbations often benefit from
oxygen at 3-4 liters per minute using a ceramic mask and Tygon 2075 tubing (to
reduce exposure to plasticizing chemicals) until significant symptom
improvement occurs. Body temperature
can drop further; a well tolerated way to assist this is a yutampo (metal “hot
water bottle” in quilted cotton sack._
It should be filled from tap water, not water heated on the stove, to
avoid burns.
The author
also recommends a baseline daily broad range antioxidant protection, often 1-11
gm of buffered C powder in water, vitamin E at 300-400 IU, micellized A at
5,000 IU, and broad spectrum bioflavinoids.
Improved pH can be achieved by testing and dietary information on foods
(Appendix V).
The proper
use of glutathione can significantly reduce the severity of exacerbations in
the author’s experience. Glutathione is
the most important intracellular antioxidant in the body. It is s are close to the breathing zone for
many hours daily, of brands and insulation is critical, since glues, certain
woods, some insulation materials and various other construction substances can
be heated up and actually exacerbate symptoms in these patients. A sauna in
which the patient is laying down has more risk of falling asleep. If the patient has such a sauna, it is
essential that it never be used without an effective timer and ideally with
another individual who would awaken the person.
Petrochemicals
are stored in fatty tissues of the body, creating a specific body burden. These chemicals are in equilibrium with
blood levels through principles of toxicokinetics such that increased fat
levels result in higher levels in blood and other body tissue. Reducing body burden can help improve
detoxification. Further, reducing body
burden is associated with reduced risk of adverse effects because of the
dose-response principle of toxicology.55
Multiple
epidemiologic studies and clinical case reports confirm both clinical
improvement and reduced body burden of various petrochemical and combustion
products with use of sauna for chemical injury. Unlike some metals, chelation is not used, but reduced body
burden is the common principle. Chronic illness following PCB overexposure
resulted in liver abnormalities and chloracne.
Following sauna therapy, symptoms improved and fat levels dropped by
over 50%.[70]
Seven individuals ill following PCB exposure were given intensive sauna
therapy for an average of 20 days.
There was an average reduction of 21.3% in fat levels of 16 organochlorines
tested.
Testing 4
months later revealed a drop of 42.4% from original levels, indicating that the
initial drop was not just a shift to other body areas.[71]
Electrical workers exposed to PCB’s and other biopersistent
organochlorines were given sauna therapy and organochlorines compared before
and after therapy with electrical workers not undergoing sauna treatment. Treated workers had a mean reduction in
organochlorine pesticides of 7.8% after treatment which by 3 months later
dropped 21.2% compared to before treatment.
Levels in untreated controls actually rose slightly (4.2%).[72]
A study of
103 patients undergoing sauna therapy used a control group of 19 persons
untreated but undergoing comparable testing.
Neurocognitive function revealed a mean increase in IQ in the treated
group of 6.7 points. Symptoms of body
aching improved in 11 of 11 persons affected, irritable bowel symptoms in 8 of
9 affected; dermatitis in 7 of 8 affected; migraine in 3 of 4 affected;
thyromegaly in 3 of 4 affected, etc.[73]
Fourteen firefighters with PCB and combustion product overexposure
showed significant impairment with sauna treatment in neurocognitive testing
for memory, visual images, block design, culture fair, trails, reaction time,
motor speed, and digits backward compared to unexposed firefighters.[74]
Eleven capacitor workers with PCB and other chemical exposure were given
sauna therapy and testing compared with untreated co-workers. Following treatment with sauna, PCB levels
in serum and fat dropped by 42% and 30% in those without concurrent disease (6
patients) and 10% in fat in those with disease. Levels in untreated controls actually increased during the same
interval. Following treatment, there
was significant improvement in symptom severity using a standard rating scale
for chloracne, other dermatologic problems, headache, and eye, respiratory,
gastrointestinal, musculoskeletal and neurologic symptoms.There was no symptom
improvement in the untreated group.71
Clinical
improvement following sauna therapy has also been documented with case reports
in several peer reviewed medical articles.
A disabled woman following soot and fire ash overexposure had severe
adenopathy, extreme fatigue, pustular acne, sleep disturbance and chronic
respiratory symptoms. During sauna
treatment a black substance began to daily exude from her pores. Following sauna therapy the acne and
adenopathy largely cleared, fatigue and respiratory symptoms greatly improved
and sleep returned to normal.73 There is also some legal precedent
that patients cannot be denied reimbursement for sauna when no traditional
therapy has been shown to be effective in reducing body burden of petrochemical
compounds.[75]
Symptom
Log
For individuals
who have waxing and waning of symptoms and/or exacerbations, a log of these
occurrences can help to identify the particular situations, exposures or other
circumstances chronologically preceding an exacerbation. This log of illness exacerbation may not be
needed long term but is helpful until exacerbating factors have been better
identified. The illness log should
focus on exposures/places/situations in the 6 to 8 hours before the onset of
symptoms or before symptom exacerbation.
Over time, review of this log can assist both the individual and the
health care provider to identify exposures and other situations which precede
symptom exacerbation. This facilitates
an information-based means of developing strategies to reduce exposures using
means described above.
Medical
Evaluation and Care
Neurologic
Evaluation
It is
recommended that patients who describe neurologic symptoms including but not
limited to confusion, disorientation, reduced memory and/or concentration,
difficulty thinking quickly or clearly, balance disturbance and/or
numbness/tingling be evaluated for neurologic and neurocognitive changes. Dr. Kilburn14 has carefully
described evaluation of brain and neurologic function from toxic exposure and
that discussion will not be duplicated here.
It is important to seriously consider his recommendations, because they
were based upon significant experience and careful epidemiologic design
evaluating many hundreds of individuals with frequent symptoms following toxic
exposures such as hydrogen sulfide, chlorine, hydrogen chloride, arsenic,
chlordane, polychlorinated biphenyls, trichloroethylene, diesel exhaust,
combustion products with a toluene rich vapor, and vinyl chloride and other
contaminants. He found Culture Fair
testing of intelligence (2A) and Trail Making B to be the most sensitive of the
neurocognitive testing. He also found
that neurophysiologic testing was often more sensitive than neurocognitive
testing, and that the most sensitive neurophysiologic testing to assess toxic
injury was balance testing (he quantitated by sway speed), blink reflex
latency, visual fields, and simple and choice reaction time. Not all toxins will affect the brain in an
identical way nor cause identical changes on testing, but review of his findings
from epidemiologic studies of the above exposure situations provides vital
guidelines for selecting the most sensitive testing approach. Sensitive testing is important to detect
brain and neurologic injury at the earliest stage to avoid further damage.
Neurocognitive
tests results can be utilized as a basis for focusing cognitive
rehabilitation. This can help the
patient to better cope with damaged brain functions and utilize less affected
areas. This is obviously not a
substitute for controlling exposure and early detection. Following
principles of occupational medicine,[76] when individuals describe cognitive,
neurologic or other symptoms which may be related to exposure, exposure removal
is recommended to ascertain whether symptoms improve. If this principle is widely implemented early in symptom onset,
much chronic and disabling toxic injury can be prevented.
Hyperbaric
Oxygen Treatment
Toxic brain
injury, also called toxic encephalopathy, is associated with reduced blood flow
to the brain[77],[78],[79],[80],[81] on SPECT scan and therefore brain
ischemia. HBOT therapy has
been shown to reduce ischemia and its damage in a wide range of tissues,
including but not limited to the nervous system.[82] Increased lipid peroxides are present in the
majority of toxic injury patients.[83]
Hyperbaric oxygen therapy (HBOT) reduces lipid peroxides.[84] It
also facilitates healing of damaged nerves in the brain as well in the
peripheral nervous system.85
Increased formation of lipid peroxides occurs with toxic injury
(directly through detoxification changes[85] with increased free radical production and
indirectly through inflammation). Cytochromes are essential to detoxification
and can be disturbed by toxic exposure. Cytochrome disturbances can improve
with hyperbaric oxygen therapy.85 Superoxide dismutase is an enzyme
important for clearing toxins from the body and is commonly reduced in toxic
injury patients.84
HBOT helps stimulate production of this enzyme.85
It has been
the author’s experience that significant and long-lasting improvement in brain
function typically occurs with HBOT which often also acts to improve multiple
other symptoms. For improvement to occur, HBOT must be properly
administered. Ideally, the chamber
should be metal rather than plastic or other synthetic material. Pressure levels of 1.3 to 1.5 atmospheres
are recommended except for patients with a history of seizures, for whom 1.25
atmospheres is preferred. No
significant complications have been described at these pressure levels in the
hyperbaric literature.81,83
To avoid exacerbation, for patients with heightened intolerance it is
necessary to utilize a chamber that does not use disinfectants which are
irritants or petrochemicals or leave any such residue. Many hyperbaric chambers are now used for
the treatment of resistant infections, utilizing significantly higher pressure
levels as well as disinfectants. A
toxic encephalopathy patient of the author who mistakenly sought treatment in
such a chamber experienced no improvement, in contrast to significant
improvement seen in all patients treated in a nontoxic chamber and relatively
nontoxic facility. This patient
experienced significant improvement with treatment at 1.5 Atm without
germicidal use in the chamber.
A treatment
of one hour duration can be conducted daily.
Follow-up is recommended during the course of therapy: after a few
treatments to ensure that improvement is occurring and there are no problems
with the treatment or facility, occasional follow-up during the course of
therapy to assess ongoing progress, (which should be occurring if the treatment
is effective), and follow-up before the treatment is terminated. Severely
affected patients may require up to two months of treatment, with lesser
duration needed for more mildly affected individuals. Once the physician can be sure that maximum improvement has been
reached, treatment can be discontinued.
In the author’s experience, benefits are typically long-lasting unless a
significant exposure occurs (an exposure sufficient to exacerbate symptoms for
weeks or months).
It is also
important to insure that the patient will be returning to a relatively nontoxic
home environment, since benefits of hyperbaric treatment can be lost if there
is significant contamination in or near the home or if significant workplace or
school exposures have not been corrected.
It may also be useful to time the hyperbaric treatment after some
reduction in body burden and after treatment for the treatable complications of
toxic injury as described below.
Hyperbaric-like
oxygen
Prior to use
of the hyperbaric chamber treatment, the author used an approach designed to
create increased oxygen availability for toxic brain injury. Blood plasma is capable of carrying oxygen
at levels which are equal to those which can be carried by the red blood cell,82,83
if sufficient oxygen is available. This
technique includes a mask designed by a respiratory therapist, with metal for
the mask and tygon tubing for the face seal.
Other equipment includes tygon 2075 tubing, a glass jar as a water
reservoir, and a wood-derived cellophane humidity mixing chamber.[86]
Oxygen is given at 6 liters per minute for two hours daily, which
requires added humidity to avoid drying the respiratory passages. On the first day, an arterial oxygen blood
draw is recommended while the oxygen is running and after one hour of oxygen
running at 6 liters per minute. The
author recommends an arterial paO2 of 250 mm of mercury for optimal effect:
oximetry testing is not satisfactory for this assessment. Virtually all patients with toxic brain
effects treated in this manner by the author for 6 to 8 weeks experienced
sustained improvement in cognitive function, but the extent of improvement was
less than that seen with the above described HBOT chamber treatment. The author feels that HBOT by chamber is
preferred when possible, but this alternative is better than no measures to
increase brain blood flow. A longer
duration may be needed for more severely affected patients.
Patient
characteristics for subsequent data discussion
One of the
most exciting developments for the author has been the growing understanding
that some aspects of toxic injury are treatable and that such treatment can be
scientific, i.e., test-based. To further
illustrate abnormalities which are more common with toxic injury, all available
test data was analyzed for 30 consecutively tested new patients who had
chronic illness, defined as two or more daily symptoms following toxic
exposure. The toxic cause of exposure
was evaluated with these criteria: 1) the patient was relatively healthy, able
to work/conduct daily activities prior to exposure; 2) symptomatic exposure with symptoms occurring during exposure
and improving away from exposure on multiple occasions (except for one patient
with a single massive propane leak exposure who had only one exposure
incident); 3) symptoms consistent with
the type of exposure; and 4) onset of
chronic illness within hours or days of a symptomatic exposure to the toxin(s). There is no overlap between these patients
and those for whom test data was described earlier by this author.30
Of these 30
patients, the most common situation of exposure was sick building/building
related, involving 9 patients. Two of
the sick building exposures involved mold and could have also involved chemical
agents to remediate mold exposure. Mold
is capable of
releasing
volatile compounds not unlike those encountered in other sick building
environments.[87],[88],[89],[90]
The most
common chemical class was pesticides, involving 9 patients and including
organophosphates chlorpyrifos (two patients), and diazinon; the synthetic
pyrethroid resmethrin; a benzyl benzoate containing dust mite spray which was
utilized on four (symptomatic) occasions by the patient to spray home carpet;
disinfectant glutaraldehyde and occupational handling of plants which had been
pesticide treated. Two of the pesticide
exposed patients involved chlordane, although they came from a very large
family where chlordane had been illegally used to treat the home by a
nonprofessional applicator. To avoid
skewing the data results, I randomly selected two individuals from the
family.
Solvent
exposure was involved with 7 patients, two of whom work in laboratories (one of
whom also had exposure to sterilizing agents and formaldehyde). Two patients were secondary to inorganic
chlorine compounds. One of these
involved passive occupational exposure to a 10% solution of chlorox used to
clean floors. The other was exposed to
sodium hypochlorite in a poultry processing operation. She was one of fourteen individuals exposed
and chronically ill from working in the evisceration department of the same
plant. Two patients were exposed to
adhesives: one a carpet adhesive, the other a drywall adhesive containing
n-hexane. Three patients were exposed
to vehicle exhaust: two to diesel exhaust entering into a building while idling
at open warehouse loading doors and one with gasoline powered vehicles used in
a building.
One of the
patients was exposed to ultraviolet inks containing acrylates and epoxies. This patient has the most severe
exacerbation by light of any patient the author has ever encountered, verified
both by history and testing. Even his
balance testing when facing the window with blinds pulled and wearing
sunglasses was much more impaired than when facing away from the window. This is strongly suggestive of a persisting
body burden. One of the patients was
exposed to medical cleaning towlettes used occupationally in a health care
setting. Some patients had multiple
symptomatic causal exposures to toxins that met the above criteria. Of the 30 patients, 25 (83%) were of
occupational origin, four were a consequence of home contamination and one was
a consequence of removing contaminated items from an office involving diazinon
treatment in an office of a chronically ill family member (who is also the
author’s patient).
Adrenal
Function Testing and Treatment
Reactive
airway disease as well as chemical sensitivity are associated with increased
inflammation.30,40 Petrochemicals when metabolized generate free
radicals[91] which can perpetuate inflammation. Inflammation often causes pain, which
induces cortisol release from the adrenal gland. Inflammation on a chronic basis can deplete adrenal reserve,
leading to adrenal insufficiency.
Like other
hormones, the vast proportion of cortisol is protein-bound when assessed in the
blood. The bound portion is not only
less active but can be affected by other factors such as the protein status,
often deficient in toxic injury patients.30 Blood assessment also
involves venipuncture, which can induce stress and may thus alter results. The cortisol daily rhythm is clinically
important as a basis for medical decisions, making venipuncture impractical for
assessing the rhythm beginning in the early morning and concluding at bedtime.
Fortunately, salivary cortisol levels show excellent correlation with plasma
levels[92],[93],[94] Salivary cortisol is collected by placing a
cotton pad in the mouth to pick up saliva as excreted without sucking motion
(since sucking can alter the composition of saliva) at 7-8 am; 11 am to noon;
4-5 pm and 11 pm to midnight, with one sample collected during each of those
four time intervals.
Of the 22
consecutively tested new patients in this group described above
(Table1), a total of 15 (68%) had reduction of morning cortisol with 9 (41%)
having changes suggesting significant adrenal insufficiency. Of the remaining five individuals, three had
elevations of two or more daily cortisol levels, one had a single modest
elevation and only one had a normal rhythm. This is further evidence of
involvement of the hypothalamic-pituitary-adrenal axis. HPA impairment makes the individual more
susceptible to physical and psychologic stressors.[95]
The mean
value of dehydroepiandrostenerione (DHEA) of those patients with two or more
cortisol elevations was 3.0, while the mean for those with two or more
suppressed values was 2.1, compared to a normal range of 3 to 10 ng/ml. DHEA is a precursor to formation of estrogen and testosterone.
It has been
the author’s experience that patients who have test-documented reduction in
morning cortisol typically experience reduced fatigue with morning cortisol
(hydrocortisone) supplementation until the adrenal gland can sufficiently
heal. It is important to endeavor to
keep added amounts to within physiologic range, striving for levels of slightly
below average in order to avoid impeding ACTH activity and ultimate recovery of
adrenal function. In this group, 32%
had elevated nighttime cortisol levels, with a mean of 9.4 nM (lab reference range of 1-4 nM for
this time interval). This nighttime
elevation can exacerbate sleep disturbance.
Phosphatidylserine may reduce the cerebral response to this cortisol
elevation when taken 30 minutes prior to the evening meal, and can be given as
a trial, but the goal is to normalize adrenal function.
To help heal
disturbed adrenal function, several measures are helpful. 1). Reducing exposure
is essential to reduce inflammation which elevates cortisol and
exacerbates pain, another factor in cortisol elevation. 2). Pain control also
requires identifying and correcting other causes of pain. Pharmaceutical intolerance in most toxic
injury patients often leads to impaired ability to utilize pain control
medication. Pharmaceuticals are typically detoxified through pathways also used
for other petrochemicals. Intestinal inflammation can be exacerbated by
parasites, candida and food intolerance, all of which are common in these
patients as discussed below: testing and test-based trestment of these is
important. A proinflammatory state can
be exacerbated by an imbalance of essential fatty acids: these should be tested
and returned to a non proinflammatory state. 3). Daily walking or very gentle
activity for up to forty minutes daily is important, although it is essential
for effectiveness in the author’s experience that this be conducted in an area
without significant irritants or pollutants. The individual should always begin gradually and never push the
pace or duration to a level which results in increased fatigue following the
activity, since fatigue exacerbation or walking in pain will not correct cortisol
disturbance. 4). Low glycemic carbohydrates are critical because insulin
release drops body glucose, stimulating cortisol release. Carbohydrates should be balanced with
adequate protein for meals and snacks: up to a 1:1 ratio in protein deficient
persons, while 2:1 may be preferable without protein deficiency. 5).
Daily/frequent measures which reduce adrenal attempts to excrete cortisol
excess (which can exacerbate depletion) can include relaxation, comedy,
mediation, biofeedback, etc.[96] according to what is preferred as relaxing
by the individual.
Amino acids:
Testing of
plasma amino acids was conducted on 27 consecutively tested chronically ill
toxic injury new patients. As seen in Table 2, the majority of these
patients with amino acids had significant deficiencies. Furthermore, the distribution of deficient
amino acids was far from random. The
most prevalent deficiency was taurine, an amino acid that is utilized in Phase
II of detoxification. It is a sulfur
containing amino acid: at least two other Phase II pathways also utilize
sulfur: sulfation using inorganic sulfates and glutathione conjugation. The second most prevalent deficiency was in
glutamine, a Phase II detoxifying agent and also used by the body to make
glutathione (the body’s most important intracellular antioxidant and a Phase II
detoxification essential substance).
The third most deficient was glycine, which is also used in Phase II
detoxification directly, to make glutathione, and to make body purines, (for genetic
material).[97] It
appears unlikely to be coincidental that the rate of deficiency was highest
among the detoxification amino acids, since many amino acids were tested. The prevalence of methionine deficiency in
this group is also instructive: methionine can be converted through biochemical
steps to cysteine (needed to make glutathione) or taurine. Both of these latter agents are used in
detoxification Phase II. Methionine is
also a methy donor, used in methylation (another Phase II detoxification
pathway).
Forty-six
percent of patients exhibited deficiency in one or more of the branched chain
amino acids: leucine, isoleucine and/or valine. Branched-chain amino acids can be reduced in chronic liver
disease and can function as neurotransmitters. They are also the only amino
acids which can enter the inner mitochondrial membrane[98] where energy generation occurs. Tryptophan (deficient in a third) is
utilized to form serotonin, which is in turn converted to melatonin,96
essential for healthy sleep. This
is another biochemical factor in sleep disturbance: reduced melatonin by
testing is common in toxic injury patients of the author. Deficiencies in phenylalanine and tyrosine
are also critical. Phenylalanine is
converted to tyrosine, which can then be converted into thyroxine, (a thyroid
hormone) or through a series of steps to neurotransmitters: first to L-dopa
which is converted to dopamine, then converted to norepinephrine which is in
turn converted to epinephrine.
Regarding tyrosine, an additional 5 (20%) were borderline deficient.
Amino acid
supplementation is ideally done with a mixture that addresses the specific
tested deficiency profile. Extra
amounts can be used as indicated: extra support for detoxification is often
useful. As with all supplementation, the focus is to correct deficiency to
ample but not elevated levels while dietary measures and environmental controls
are implemented to maintain adequate levels.
It is the author’s experience that amino acids and minerals are
difficult to bring to adequate levels (at least average as a minimum for repair
of toxic injury) without stabilization of disturbed adrenal function using the
approaches described above.
The author’s
treatment approach has been to base repletion on test results. This can be done with a formulated powder
whose composition is modified according to the precise deficiencies
present. Unless environmental and other
controls are adequately eliminated to control most exacerbations, or in
patients using medications (the vast majority of which are detoxified through
similar pathways as nonpharmaceutical petrochemical compounds), additional
supplementation of amino acids necessary for detoxification is often
useful.
Energy
metabolism:
Foods are
converted into energy through a multistep process in the intracellular structures
called mitochondria. The author earlier
documented disturbances of energy metabolism in all of 20 additional
consecutively tested patients who were chronically ill following toxic exposure30
by measuring metabolites in the urine from each of the multiple steps in
energy metabolism, (often known to physicians as the Kreb or TCA cycle of
energy metabolism). Recently a more cost-effective test was introduced which
assesses energy metabolism only. As of
this date, only six energy metabolism test results are available from the
patient group described in this paper.
While this is a small number, all 6 had impaired energy metabolism, with
5 having impaired function at two or more steps in the energy production cycle. Lactate levels were normal in all six and
pyruvate reduced in one (other 5 normal). However, all 6 had reduced
hydroxymethyglutarate, which was found in half of the previously tested group.30 Despite the small numbers, the results have
striking similarity to the earlier tested group, even though the two groups
were tested in different laboratories, lending further support to validity.
The results
from energy metabolism can be utilized by a health care provider with some
knowledge of the biochemical cofactors which are necessary for the various
steps. As a clinical example, one of
the patients tested low in alpha ketoglutarate, which feeds directly into
the electron transport chain of energy generation, which is vital to all body
functions. The immediate preceding
step, isocitrate, requires vitamin B3 (as NADH), magnesium and maganese. Mineral testing on this patient showed
reduced magnesium and a low normal manganese.
With this particular test, a diagram is provided to the physician
listing necessary cofactors so the results can be readily compared with other
testing to determine the extent of clinical significance for energy generation
in fatigue patients who have either deficient or low levels, guiding the
supplementation process and dietary recommendations.
Energy
metabolism testing is also useful to help determine biochemical causes of
fatigue and to assess, following treatment, whether energy production has
reached more normal levels. Because
hydroxymethylglutarate is necessary for the formation of coenzyme Q10, a vital
antioxidant for energy production in the inner mitochondrial membrane,97
supplementation with coenzyme Q10 is useful to address this disturbance
until/unless the more basic problem can be corrected. The above discussed deficiencies of branched chain amino acids
are also important for energy metabolism, because these are the only amino
acids which cross the inner membrane of the mitochondria where energy
metabolism occurs.99
Additionally, carnitine is essential as a shuttle to allow fatty acids
to pass into the mitochondria to be utilized for energy metabolism, so
carnitine deficiency can also interfere with energy metabolism. It would thus be useful to have a more
direct measurement of carnitine adequacy.
Increased adipate or suberate (medium chain fatty acids) often occur
with carnitine deficiency. For the 20
previously evaluated toxic injury patients,30 adipate was increased
in 30 percent, with none of the patients showing decreased levels, suggesting
that carnitine deficiency could also be a factor in reduced energy metabolism
in toxic injury patients.
A wide range
of toxic substances have been documented to impair energy metabolism,
including phthalate plasticizers,
styrene, polychlorinated biphenyls, toluene, trichloroethane,
2,4,6-trichlorophenol, pentachlorophenol and other pesticides. For example,
toxic injury patients with fatigue could have exacerbations from food/beverage
containers with phthalates (soft plastic) and medical equipment using such
plastics: soft IV bags, much IV tubing, many oxygen masks, etc.99
Detoxification:
Detoxification
capability was assessed in 21 consecutively new tested patients (Table 3) and,
as for all other tests, data is presented for all of the 30 patients who
completed the respective tests by the time of the manuscript preparation. Detoxification of petrochemical compounds
typically involves two steps or phases: Phase I involves the cleaving of part
of the molecule to create a free radical which must then be linked with another
substance in the second step, often called Phase II.
The first
step involves the cytochrome p450 system, which has several dozen
subtypes. For this assessment of
detoxification, which is a true challenge testing, 200 mg of caffeine is taken
by mouth (tablet) to assess a common p450 isomer: only three patients had
disturbed function, with two of those having increased function and thus likely
to form increased free radicals. This
does not rule out abnormal Phase I function for other p450 isomers.
Four Phase II
pathways were assessed using a single dose of acetaminophen of 650 mg to assess
glutathione conjugation, sulfation and glucuronidation; and 650 mg of aspirin
(two aspirin tablets) to assess glycine conjugation. Urine is collected for metabolites 10 hours after acetaminophen
and aspirin challenge. In this group of
new patients, excess activity of Phase II was the predominant abnormality, and
was found in the majority of patients, with four patients actually having
excess activity in all four tested Phase II pathways. It is felt that excess activity is likely to precede reduced
activity, the latter occurring when depletion of the necessary substances such
as glutathione, glycine, sulfate, etc. occurs.
Other Phase II conjugation pathways which cannot be assessed with these
challenge substances include conjugation with glutamine, taurine, methyl groups
(such as from methionine, folate etc.), and conjugation with an acetyl group.55,97
The increased
lipid peroxides found in over one-third of tested patients is of grave concern:
lipids comprise nearly two-thirds of the content of the brain, as well as
forming membranes for body cells, for the billions of body mitochondria (energy
metabolism occurs in the mitochondrial membrane), and membranes around genetic
material (DNA). Obviously, converting these essential lipids into peroxides
damages their function. All cell nutrients must pass through the
lipid/essential fatty acid cell membrane and all waste products must pass out
of this membrane. Damage to such lipids
may be repaired by the body using the wrong fatty acid/lipid in an attempt to
prevent cell death, but normal lipid/essential fatty acid composition has been
altered. This concept is discussed
further below.
The large
portion of patients who had glutathione deficiency is a further indication of
the need to preserve glutathione levels, by reducing exposure, utilizing
nebulized glutathione and conserving the reduced (active) state of glutathione
by adequate levels of buffered vitamin C.
Alpha lipoic acid also helps to conserve glutathione and is able to
access water and fat-soluble body tissues. Glutathione cycling in the body
requires an adequate selenium level99
but excess can be toxic, so testing is useful.
Superoxide
dismutase (SOD) functions as an antioxidant to reduce tissue damage from free
radicals and was reduced in 33%.
Necessary cofactors for its adequate functioning include copper, and
manganese,99 emphasizing the need to evaluate mineral status to
identify factors underlying reduced SOD functions. Despite ample or excess activity in Phase II pathways in these
tested patients, over half had a high level of free radicals, emphasizing the
need for antioxidant protection.
Increased free radicals have been associated with degenerative and
chronic diseases,[99] stroke and heart disease,[100],[101] cancer,[102],[103] cognitive decline,[104],[105] the rate of aging,[106] and can damage enzymes and other proteins,
cell membranes, nerve cells and virtually any
other body tissue.
Essential
Fatty Acids in Cell Membranes
Following the
publication of Dr. Simpson,[107] a world renowned researcher on red cell
morphology, the author undertook an evaluation by submitting samples on 20
chronically ill toxic injury patients, to be interpreted by Dr. Simpson without
any knowledge of diagnosis. All 20 had
altered red blood cell morphology, all with a reduced proportion of discoid
cells and an increased proportion of flat cells. This alteration in RBC morphology would impair the ability of the
cells to pass through the capillary, because the red cell is about 7 microns in
diameter and a capillary is only 3-4 microns.
The cell must therefore flex to pass normally through capillaries, and
disc shaped cells flex much better than flat ones. The study with Dr Simpson
also showed a substantial minority of patients with even more bizarre forms of
altered morphology.
After the
author’s patient testing by Simpson, the author began to assess RBC membrane
lipid composition, in an attempt to improve brain blood flow and other cell
functions. Some preliminary information was published earlier.30 Impaired tissue perfusion in the brain has
been documented in toxic injury patients by several authors.32,33,34
All patients
in this group of 30 who had completed RBC membrane essential fatty acid testing
have data displayed in Table 3 (25 patients); 17 of these had specimens sent to
one laboratory[108] and eight patients in another laboratory.[109] Because the first laboratory reported results
in weight percent, while the second in micromoles, the data were displayed
separately.
Omega 3
essential fatty acids include alpha linolenic (ALA), eicosapentanoic (EPA), and
docosahexanoic (DHA) The proportion of patients from the two laboratories which
had a deficiency of one or more of these Omega 3 essential fatty acids was 76%
and 88% respectively, while none of the 25 patients had an increase in either
laboratory.
The Omega 3
essential fatty acids are anti-inflammatory.[110] ALA
can be converted to EPA which then may be converted to DHA. Further, DHA has a high concentration in the
cerebral cortex, comprising about 30% of the essential fatty acid in
phosphatidylserine and phosphatidyl ethanolamine.109 Because the enzymes which convert ALA to the
other essential fatty acids could be impaired by free radical damage, it is
recommended that essential fatty acids be tested separately, as was done for
these patients. ALA appear to be
involved with the transfer of oxygen from air into the lungs, across the red
cell membrane to hemoglobin, and appears to hold oxygen in the cell membrane
where it can assist as a barrier to viruses, bacteria, etc.[111] Cell membrane rigidity/fluidity is also
affected by essential fatty acid composition of cell membranes, with Omega 3
essential fatty acids creating a less rigid membrane.109 Thus the reduction in Omega 3 essential
fatty acids in the RBC membranes of toxic injury patients could impair the
ability of the red blood cells to pass through and flex in the capillary,
reducing tissue perfussion and nutrient/waste product exchange between the
blood and other body cells.
GLA is the
precursor of dihomo-gamma-linolenic acid (DGLA), which is also
anti-inflammatory, being a precursor for the series one anti-inflammatory
prostaglandins in the body.
Arachidonic
acid (AA), is an essential fatty acid that when found in excess can be
proinflammatory.111 Arachidonic acid forms proinflammatory
leukotrienes, which attract white blood cells called phagocytes and
polymorphonuclear white cells during inflammation.111 As can be seen in Table 4, a high proportion
of patients showed increased proinflammatory arachidonic acid, while none of
the 25 showed reduced levels. The
combination of a high proportion with reduced anti-inflammatory essential fatty
acids and a high proportion with increased proinflammatory arachidonic acid is
consistent with the proinflammatory symptoms in these patients: increased
aching, respiratory congestion, etc..
The author’s
approach to correcting membrane essential fatty acid composition is to base
recommendations upon test data. EPA,
DHA and GLA are available in a micellized form that is absorbed without the
necessary activity of digestive pancreatic enzymes, which are often deficient
in toxic injury patients30 and further documented below. Essential fatty acids can be damaged by
contact with light, heat or air, so sealed containers are advisable and
refrigeration is recommended. Dietary
recommendations are an important part of patient care. The richest dietary sources of EPA and DHA
are naturally grown cold water fish such as mackerel, salmon, sardine, blue
fish, herring, trout, and whitefish.111 Up to four grams daily of omega 3’s may
be needed to suppress excess inflammatory response.111 Because
individual food preferences vary, the author’s approach is to encourage
increased consumption of such fish, but as with any food, not to urge
consumption for individuals who have a dislike of the specific fish or other
foods. Fish oil may be more useful than
aspirin and other cyclooxygenase (COX) inhibitors in suppressing chronic
inflammation.111 The source
of fish is important in its omega-3 content, because fish who eat omega 3 algae
and phytoplankton in the wild are likely to have a higher omega-3 content than
farm-raised fish without an ample level of omega-3 in their diet. Arachidonic acid is rich in red meat and
shellfish, but does not appear to be the sole and perhaps not a primary source
of these elevations, since some of the patients were vegetarians and others did
not eat these foods.
Gastrointestinal
testing
Table 5 illustrates
gastrointestinal abnormalities found in all consecutively tested new toxic
injury patients. Secretory SIgA was
evaluated in the stool, and was deficient in 87% of those tested, with striking
similarity to the high portion reduced as reported earlier by the author on
other toxic injury patients.30
SIgA levels on many patients were severely deficient. This could increase the potential for
infection, which was also commonly found as illustrated on Table 5. The potentially ulcer-inducing parasite, H.
pylori, was evaluated by IgG antibodies specific to H. Pylori. Entamoeba histolytica was evaluated by
salivary secretory IgA specific antibodies which are more likely to detect
amoeba-induced intestinal infection which is invasive. Toxoplasma was assessed
by secretory IgA-specific antibodies to toxoplasma: the test had only been
introduced recently, but over half of the 7 tested patients were positive. Giardia and cryptosporidium were both
assessed by organism-specific antibodies.
Evaluation for Clostridium dificile utilized toxins A and B, which is
more sensitive than the use of a single toxin alone. While the use of the parasite testing approach described is
considered more sensitive in parasite detection than viewing the stool samples
under the microscope (in the hope of detecting the evidence of a parasite in a
tiny drop of stool specimen), the laboratory utilized three microscopic
evaluations for ova and parasites in addition.
The original contact source for the various parasites could have been
food and/or water, depending in part upon the specific parasite’s life cycle.
Parasites
were treated by antibiotics, and retesting was conducted to verify cure. The specific antibiotic regimen was varied
slightly to improve the ability of these patients to tolerate treatment. The author does not recommend herbs to kill
these parasites because of concern not only regarding efficacy but also because
some parasites, such as E. Histolytica and toxoplasma can migrate to other body
organs.
The following
are treatment regimens recommended by the author.
Toxoplasma
has responded well thus far to Mepron at 750 mg (1 teaspoon liquid) twice daily
with food for 21 days. With use
of Mepron, liver function testing (SGOT, SGPT, GGT) before treatment and after
7-10 days of treatment is recommended.
For E. Histolytica, a triple therapy is recommended to clear the
parasite from the intestine and any organisms that have spread to other body
areas, using Yodoxin 650 mg three times daily and generic tetracycline (which
is retained largely within the intestine) at 500 mg three times daily for 10
days, then Tinidazole 500 mg three times daily for 7 to 10 days. Tinidazole is closely related structurally
to metronidazole, but the former appears better tolerated and, based upon
retesting results, appears effective.
H. Pylori appears to respond well to a regimen including Tinidazole 500
mg three times daily with meals and Bismagel one teaspoon 30 minutes before
meals, taking both for 10 days, and Amoxicillin 500 mg three times daily with
meals for 10 days. The recommended
treatment for cryptosporidium is Tinidazole 500 mg three times daily for 10
days. Following antibiotic therapy, the
author has used human strain probiotics (acidophilus, bifidus, etc.), which,
unlike the nonhuman strains comprising the vast majority of available brands,
appear to remain functional because they can multiply and sustain their
population in the human intestines.
Like an
earlier tested group of toxic injury patients,30 a substantial
proportion of these patients had Candida, usually Candida albicans. This was assessed on culture, although
microscopic examination was also done by the laboratory (microscopic results
for Candida were not added to Table 5).
Candida are opportunistic organisms and are sufficiently ubiquitous in
the environment that reinfection is likely unless the factors which allow them
to flourish in the gut are addressed.
These factors include adequate digestive enzymes (deficient in 73% of
those tested in this group and 60% of an earlier tested published group30).
Gastric acid deficiency, insufficient human strain acidophilus and/or
bifidis (which secrete enzymes to help digest sugars) are also factors which
allow Candida to flourish. In the author’s experience, evaluating and
controlling these risk factors as well as a Candida diet has been adequate to
control Candida without the use of antibiotics such as Nystatin, Diflucan,
etc., except for a very few patients who had been placed on steroids for
medical conditions such as autoimmune disease (not including patients in this
group of 30).
Chymotrypsin
is a marker enzyme for pancreatic digestive enzyme output: low chymotrypsin
levels suggest reduced pancreatic output of other pancreatic digestive enzymes.
Digestive enzyme deficiency can impair the ability to obtain adequate nutrient
content from food, because food must be adequately digested through pancreatic
enzyme action. In the author’s
experience, reduced chymotrypsin often persists for years in toxic injury
patients. Digestive enzyme
supplementation with food at mealtime is recommended. Reduced digestive enzyme output could lead to food intolerances,
because incompletely digested foods are more likely to be antigenic. As
demonstrated on Table 5, the majority of tested patients showed secretory IgA
specific antibodies to one or more of the foods evaluated: milk, soy, and
egg. Food intolerance assessed by other
means, such as ELISA-ACT and IgG-specific antibodies show multiple food intolerances
in the vast majority of tested toxic injury patients of the author, although
this data has not been quantified. Avoiding foods to which an individual has
intolerance has improved symptoms in the author’s experience, particularly
fatigue and aching. After an interval
of avoiding the food, some patients can tolerate reintroduction of the food on
an occasional basis. Clinical nutritionists often recommend an interval of up to once every four days,
based upon the three-day transit of food through the intestinal tract. For patients testing as gliadin (gluten)
positive, elimination of gliadin-containing foods would include those
containing wheat, rye, barley, oats and kamut.
Such patients may eat corn, and may tolerate quinoa and amaranth in
modest amounts because of the small and well tolerated glutens in these
grains. Patient response to food
reintroduction after a three to six month interval of elimination can utilize
the illness log approach discussed above, if the patient understands that foods
remain in the intestines for about three days, so that symptom exacerbation can
occur on a delayed basis.
Red Blood
Cell Minerals
Intracellular
mineral levels was used as the preferred technique because it is less
influenced by recent dietary intake and because these minerals have passed the
cell membrane, the composition of which is disturbed as described above. Patients were tested using one of two
different laboratories as indicated on Table 6, depending in significant part
on the Medicare status of the patient, although the author prefers more
comprehensive testing of laboratory
one.
Calcium was
found deficient in none of the tested patients and is generally uncommon in
toxic injury patients. Calcium is
widely used as a supplement in the general population and is often added to
foods as a supplement.
Chromium was
deficient or borderline low in a substantial proportion of patients tested. The
assessment of borderline low was a clinical judgment of the author based on
test results: these patients were well below the lower 25 percent of the normal
range. Levels needed to repair toxic
injury are felt to be above average level and may well be in the ample range
although intracellular levels in the excess range are not recommended.
Chromium
losses are increased through tissue trauma.111 Chromium is probably transported in the
blood by plasma protein known as transferrin.111 With the widespread protein deficiency in
these patients, carrier proteins could be reduced. Chromium deficiency is associated with glucose intolerance and
elevated cholesterol and triglycerides.111 The density of insulin receptors is enhanced by chromium
supplementation, and cholesterol elevation is significantly reduced.111 Dietary levels are often insufficient111
and thus diet changes are difficult to utilize as a sole means of correcting
chromium deficiency. Inorganic chromium
salts are poorly absorbed,111 and like other minerals, chromium is
better absorbed as an amino acid chelate (the specific chelate can be selected
using those deficient in the cellular energy testing, for example citrate,
aspartate etc. or linked to picolinate.
Picolinic acid is considered the binding agent secreted by the pancreas
to assist mineral transport.[112]
Deficiency of
copper is significant because it is essential for the function of the
detoxification substance superoxide dismutase,99,111 often deficient
as displayed on Table 3. Copper is also
a necessary component of some cytochrome oxidase hemoproteins which are an
essential component of the mitochondrial system of generating energy.98,111 Copper may compete with zinc for absorption,111
although that does not appear to be the cause of copper deficiency in this
patient group, given the low levels of zinc on testing. Copper requires carrier proteins, first
using albumin and later ceruloplasmin.111 Carrier proteins could be affected by the widespread protein
deficiency in these patients as illustrated in Table 2. Copper is also incorporated into liver
enzymes,111 which could be affected by exposure to hepatoxic
agents. Copper absorption is an
energy-dependent process,111 and impaired energy metabolism
as discussed above in toxic injury patients could affect absorption. Copper is
also involved in the healing of inflammation and tissue repair.111 Therefore there could be multiple mechanisms
of copper deficiency in toxic injury. Copper deficiency may contribute to
cholesterol disturbance, particularly elevation of low-density lipoprotein
(LDL), the “bad cholesterol”.111
Only one of the tested patients showed elevation of copper, suggesting
the need to evaluate supplementation and/or Wilson’s disease. Copper is also best absorbed as a chelate
which increases water solubility. Foods
rich in copper include whole grains, nuts, and legumes as well as avocado.111
Magnesium was
the most common essential mineral deficiency in these patients. Magnesium absorption is reduced with
intestinal malabsorption.98,111 Magnesium loss is increased by acidosis, which is also common in
toxic injury. Twenty percent of these
patients had urinary pH at first visit of less than 5, and an additional 40%
were at 5 pH. Clinical nutritionists consider a urinary pH of 6 to 7 optimal.
Magnesium deficiency enhances muscle irritability;111 symptoms of
muscle twitching, cramping, jerking and/or muscle spasm are common in the
author’s toxic injury patients. When
present, these often improve within 30-40 minutes with a rapidly absorbed form
of oral liquid magnesium chloride/acetate designed for rapid absorption in heart
patients. The rapid action assists in
evalutation of magnesium’s role in the symptoms. Magnesium deficiency can exacerbate smooth muscle constriction,
with implications for blood pressure.111 High blood pressure in
magnesium-deficient patients may respond to correcting magnesium deficiency, as
may other conditions involving vascular spasm.
This has applied in the author’s patients with angina, using
nitroglycerin, oxygen etc. as well.
Once magnesium deficiency is corrected, nitroglycerin need may decline,
particularly if vasospasm was the primary mechanism inducing angina. Magnesium is also required for many
ATP-dependent enzyme reactions111 and is a necessary cofactor for
the conversion of carbohydrates and fats into energy and for at least 2 steps
of the energy metabolism cycle. Adequate
magnesium is also necessary for normal bone mineral metabolism,109
and the majority of the body’s magnesium content is located in the bone.111 It is important in toxic injury patients to
utilize well absorbed forms of magnesium when needed for supplementation to
prevent loose stools. Forms can include
magnesium glycinate, which also can improve glycine levels for detoxification,
or an amino acid chelate, particularly using substances necessary for energy
metabolism such as citrate, etc..
Magnesium in the diet can be increased by increasing magnesium-rich
foods such as whole grains, nuts, seeds and chlorophyll rich leafy plants.98,111
Manganese is
essential for energy metabolism, the detoxification substance superoxide
dismutase, the formation of essential substances for cartilage (hyaluronic acid
and chondroitin sulphate), for bone mineralization, and for formation of
membrane phosphatidylinositol.111 Blood distribution probably
involves transferrin proteins,111 with implications for protein
deficiency. Absorption may be increased
by citrate and reduced by calcium, iron and phytates in the diet.111 Good food sources include whole grains,
nuts, and leafy vegetables. The richest grain source is in the germ.111
Molybdenum
deficiency was particularly common in these patients in both testing
laboratories. It is used to detoxify
aldehyde compounds.111 It
is also necessary for the conversion of cysteine to sulfate for detoxification:
cysteine to sulfate ratios were decreased in over a third of the tested
patients, as illustrated in Table 3. It
is also required for inactivation of the otherwise destructive sulfite compound111
and in other oxidase enzymes containing flavin.111 Molybdenum is found in the germ of grains
and probably the legumes (beans).111 For supplementation it is best absorbed as an amino acid chelate
or picolinate.111 Dietary
absorption is good except in the presence of sulfate or enhanced sulfur
containing proteins (which may be necessary for toxic injury patients), so
timing of intake should be adjusted accordingly.
The vast
majority of body potassium is located within cells, not blood plasma,111
so the commonly utilized medical measurement of potassium in plasma could
significantly underestimate intracellular deficiency (although plasma levels
are also essential to control for medical reasons). Potassium is essential for normal membrane function including but
not limited to nerve cell and neurotransmitter function.111 Potassium listed on Table 5 was not drawn
during episodes of exacerbation. In the
experience of the author, potassium may drop during exacerbation following
exposure, but because of the relatively narrow range of safety for potassium
supplementation, it is useful to assess whether this occurs. Many potassium
supplements can be irritating to the intestinal tract, which may often be
avoided by using potassium chloride as a salt and/or potassium bicarbonate in
patients who are acidic during exacerbations.
As discussed above, pH levels are a useful guide for decisions regarding
bicarbonate compounds during exacerbation.
Selenium
deficiency interferes with glutathione peroxidase111 and deficiency
can thus reduce levels of glutathione, commonly deficient as illustrated in
Table 3. Glutathione peroxidase plays a
role in the detoxification of peroxides and free radicals.111 Selenium is also necessary for the
deiodinase enzyme that converts the less active thyroid hormone T4 to the
active thyroid hormone T3. Glutathione peroxidase activity improves with
selenium supplementation, as selenomethionine,111 although selenium
can also be administered in well absorbed amino acid chelate or
picolinate. Food content of selenium
depends significantly upon soil content.111 Selenium rich foods include garlic and
onion family foods, asparagus, grains grown in selenium-adequate soils, meats
and seafood.111
Vanadium may
bind to glutathione.111 It
is important for glucose metabolism, being able to mimic the effect of insulin
on fat cells, although subsequent metabolism may prefer the pentos pathway more
than insulin.111 Vanadium
may also stimulate mineralization of bone by promoting osteoblasts, and may
also be important in cholesterol metabolism.111 Vanadium is carried by the plasma protein
transferrin,111 like certain other essential minerals
discussed. Vanadium has a low efficiency of absorption and the American food
supply often contains low levels, but such levels can vary by several orders of
magnitude,111 which can reflect soil content. Since vanadium is potentially more toxic
than chromium,111 the author prefers to address chromium adequacy
first prior to vanadium supplementation, because chromium helps to spare the
body’s vanadium reserves.
Zinc
deficiency was common, as illustrated in Table 6. Zinc is essential for normal
function of the detoxification substance superoxide dismutase99,111,
commonly deficient in these patients as illustrated on Table 3. Superoxide dismutase, which requires both
copper and zinc, is present in all body cells. Red blood cell levels play an
important role in controlling superoxide free radicals,111 helping
to protect other cells from this free radical. Zinc is necessary for the activity of more than 100 body
enzymes, including those associated with carbohydrate and energy metabolism,
protein synthesis, synthesis of other vital body structures and pancreatic
digestive enzymes,111 which were often deficient as illustrated on
Table 5. Zinc is also necessary for
normal function of vitamin A (an antioxidant) and is critical to normal immune
function.111 It may also be required for normal
activity of adrenocorticotropic hormone (ACTH),111 which is secreted
by the pituitary to stimulate adrenal cortisol production, the latter being
commonly deficient in toxic injury patients as discussed above. Increased zinc loss can occur with injury.111
Pancreatic insufficiency can also cause zinc deficiency.111 Increased loss from the body can also occur
with liver disease, porphyrin disturbance and parasitic infection.111 Porphyrin disturbance is common in toxic
injury1 as is parasitic infection,30 as further
illustrated on Table 5. There are thus
multiple potential mechanisms for zinc deficiency in toxic injury.
Essential
minerals deficiency was thus common by testing of toxic injury patients. Chronically elevated cortisol leading to
adrenal insufficiency (see discussion above) can deplete minerals as well as
proteins. Reduced carrier proteins for
some minerals could reduced effective transport to body cells. Impaired digestive enzymes as illustrated on
Table 5 can impair adequate breakdown of food, making minerals less
bioavailable for absorption. Chronic
gastrointestinal inflammation can reduced absorption and/or accelerate loss of
minerals. Such inflammation could be
secondary to intestinal parasites (common as illustrated on Table 5) and in
earlier work by this author,30 and also increased through a
generalized proinflammatory state as illustrated in Table 4. Further, neurogenic inflammation in toxic
injury involves the gastrointestinal tract and genital urinary tract as well as
the respiratory tract because of its systemic nature.40 The detoxification role of zinc and copper
(in superoxide dismutase) and molybdenum (in converting organic to inorganic
sulfates for Phase II sulfation) are further mechanisms of mineral deficiency
in toxic injury.
Other
Nutrients
The other
nutrients displayed on Table 7 were tested with a different technology that
involves assessing, for each nutrient, the ability of lymphocytes to divide and
form new cells. Unlike nutritional
assays relying on plasma levels, transport in the bloodstream and cellular
uptake is taken into consideration with this technology. With the membrane disturbances described
above (Table 4), this is particularly important. Further, lymphocytes traverse
through lymphatic fluid, which is lipid based, with increased potential for
exposure and effects of lipid-soluble chemicals. Such chemicals can affect other lipid tissues such as the brain,
with its high lipid content, and cell membranes as discussed above. Further, nutrient need for repair of tissue damage is higher than the mere
maintenance of healthy body function, and levels alone do not readily take into
consideration nutrient need. This is a
factor, however, with this particular lymphocyte assay, because the function of
cell division is a demanding one and reflects nutrient need. The technique has been further described in
the medical literature.[113]
Thiamine is
important in two steps of energy metabolism and converts to a coenzyme
(thiamine pyrophosphate) for these functions as well as for essential
metabolism of all cells including the brain.111 Reduced levels can exacerbate impaired
attention span, memory, and peripheral neuropathy.111 It may also play a separate role in brain
cell viability, i.e. ability to survive.111 The brain is a high energy utilizing
organ.
Riboflavin is
also critical to energy metabolism.111 It functions as part of two co-enzymes (FAD, and FMN). Riboflavin is also essential for the
production of the critical energy substance adenosine triphosphate (ATP).111
In patients with more severe deficiency, redness or inflammation of the tongue
and/or the corners of the mouth may be seen,111 but this is insufficiently
sensitive to serve as a substitute for testing.
Niacin is
also called nicotinic acid. It is
converted by the body to an essential substance called nicotiniamide adenine
dinucleotide (NAD), which is essential for energy metabolism, and for the
utilization as well as the synthesis of essential fatty acids.
Thus thiamine
(vitamin B1), riboflavin (B2) and niacin (B3) are all involved in energy
metabolism, which is essential to the function of every cell, enzyme and other
body function. Forty-three percent of
the patients tested were deficient in one or more of these nutrients. Deficiency was defined by the laboratory as
less than two standard deviations below the mean of a large comparison control
population,114 and patients with low normal levels were also very
prevalent for these nutrients.
Pantothenate
(B5) is essential for coenzyme A, which is necessary for energy metabolism and
burning of fats by the mitochondria.111 It is also essential for the
body’s synthesis of phospholipids needed for the brain and other cell
membranes.111
Pyridoxine
(B6) is necessary for the formation of transaminase liver enzymes. It is also critical to the formation of
other amino acids from essential amino acids through transaminases.111
Further, it is needed for the
formation of neurotransmitters serotonin and gamma-amino butyric acid (GABA),
porphyrin metabolism, synthesis of brain lipids, taurine synthesis and
glycine synthesis.111 As
discussed earlier, both taurine and glycine are used for detoxification.
Cobalamin
(B12) was deficient in the majority of these patients, having a higher rate of
deficiency than any of the other B vitamins.
Vitamin B12 is needed for the maintenance and repair of myelin, the
essential coating of nerve cells. It is also a key nutrient in the
s-adenosylmethiomine (SAM) cycle which provides methyl groups for
detoxification in Phase II methylation.99 Deficient levels can also
impair melatonin secretion.[114] Adsorption
is more complex than for other vitamins, and requires a carrier protein.111 Other carrier proteins are required for
transport in the blood.111
Deficiency exacerbates neurologic function.98,111
Total
antioxidant function is an evaluation of the combined antioxidant capability of
various individual antioxidants, with methodology more completely described in
the literature.114 Nearly
three-fourths of the tested patients showed deficient levels with numerous
others at below optimal capability, particularly given the significant
proportion with increased free radicals (Table 3).
Other
Endocrine Changes
Melatonin levels at night have been low in a high
proportion of the author’s previously tested toxic injury patients. Melatonin functions as an antioxidant for
hydroxy free radicals[115] (increased in one third of these patients,
Table 4). Patients with reduced
melatonin could benefit from several measures.
Ensuring tryptophan at adequate levels provides the precursor for
melatonin generation.98 Tryptophan containing foods include eggs,
low-fat milk, beef, chicken, turkey, soy products, nuts, tuna, beans, banana,
and oatmeal. Indirect sunlight (15
minutes in the spring and summer, 45 minutes in the fall and winter) and full
spectrum daytime lighting can help improve melatonin daily rhythm.116
Reducing evening light levels and electromagnetic fields, especially near
bedtime, is useful. Thus electric
blankets, L. E. D. clocks at the bedside, etc. may exacerbate sleep in affected
patients, and a trial without these is useful.
Melatonin is excreted by the body after passing through Phase II
sulfation and to a lesser extent, glucuronidation.98 The author is
cautious about exogenous melatonin administration. If the above measures do not suffice, 1 mg, ideally sustained release can be used. In animals, excess exogenous melatonin can have adverse effects
on other endocrine functions.116
At this time, the extent of melatonin recovery is unknown in toxic
injury. Melatonin levels decline with
aging,116 and free radicals accelerate aging, as discussed
above. Free radicals are common as
illustrated on Table 4.
Reproductive
hormones in the author’s
tested toxic injury patients have shown significant disturbance. For women of reproductive age, lack of
ovulation is present in a substantial majority, and estrogen dominance is very
prevalent. The latter is also common in
postmenopausal toxic injury patients tested by the author. This has major implications. Estrogen dominance has been associated with
increased risk for breast and some other reproductive cancers.116 Estrogen dominance can also exacerbate
migraine. Exogenous estrogen
administration is commonly done by physicians for postmenopausal women, and
this can exacerbate estrogen dominance of toxic injury patients. Progesterone deficiency is often but not
always present with estrogen dominance in these patients. Because reproductive hormones affect many
body functions, levels should be kept within physiologic range.116 This requires testing prior to hormone administration. Since synthetic hormones are not readily
tested regarding their physiologic effect on patients, natural hormones are
preferred because levels can be evaluated post-treatment by testing. Natural hormones also appear to be better
tolerated in these patients. Reduced
testosterone is not uncommon in the author’s tested patients; this change can
lead to reduced muscle strength as well as lower libido in males and females.116
Thyroid autoimmune disease is the most common
autoimmune disease in the author’s toxic injury patients. Further quantification of thyroid changes is
useful, particularly given fatigue in these patients. Thyroid hormone treatment
is not recommneded without thyroid testing. Low body temperature can have other causes. The author does not use the practice of
thyroid hormone treatment to elevate low body temperature without testing
thyroid function. With limited energy
metabolism and high energy needs of the brain and heart, taking limited energy
reserves to elevate body temperature by above physiologic thyroid stimulation
seems unwise. Further, the author’s
patients temperatures tend to return to more normal levels as their health
improves.
The average
(mean) sublingual body temperature (assessed for all 30 patients) on initial
visit was 97.4o, with 80% having a temperature under 98o
and 23% under 97o. This is
consistant with impaired energy metabolism.
It also illustrates the fallacy of using temperature alone to make
decisions on thyroid hormone treatment.
Other
Changes
Medication
intolerance is common. Sicker patients
often experience sufficient side effects that for many medications intended for
symptom relief, the patient often feels side effects outweigh benefits. For medications that are essential for
correcting a condition, reduced dosage is often effective and lowers side
effects.
The decision
of whether antibiotics are needed is more complex than with most other
patients. The patient whose temperature
usually runs in the 97o range will, when feverish, often not achieve
temperatures near 100o. The
author encourages patients to periodically monitor their temperature when they
feel at their usual symptom level to establish a baseline. If later the patient feels feverish and their
temperature at that time is elevated about a degree or more above baseline,
this suggests their body may be going into a fever mode. Total white count often runs low to low
normal in sicker patients, and during bacterial infection often does not rise to
exceed laboratory range. Again,
periodic baseline measurement is useful.
During bacterial infection, however, the percent of neutrophils rises,
which the author has found to be a valuable assessment. Culture and sensitivity is particularly
important in antibiotic selection, given low Secretory IgA and medication side
effects.
Some patients
describe irregular heart rhythm during exposure. Here a Holter monitor before, during and after a typical exposure
(eg., going into work) can be useful. A
peak flow meter can be used in the same way (before, during, after) if there is
a question whether a particular situation or condition is exacerbating lung
function.
In the
author’s experience, a minority of patients with toxic injury develop increased
blood pressure. Of those who do,
however, the predominant pattern is normal pressure when not exposed and
elevations only with exacerbating exposures.
If blood pressure is elevated only in a medical setting, elevated levels
are typically seen with this pattern, which involves measuring levels after
vehicle exhaust, etc.. Home blood pressure monitoring is recommended to
determine whether the blood pressure elevation also occurs at home prior to a
decision on medication.
Summary
Exposure
control is the single most important intervention for toxic injury, focusing on
locations where most time is spent (work, school, home). Medical providers can assist in obtaining
necessary reasonable accommodation, placing primary emphasis on the patient's
health. Exposure controls are also
needed as a basis for all other treatment.
Toxic brain
injury can also be treated with hyperbaric oxygen at proper pressure levels and
other precautions and ensuring adequate nutrients for energy generation and
other functions. Cognitive rehabilitation
helps, coping with residual effects.
Some residual often occurs with toxic brain injury. Autonomic neuropathy can be associated with
irregular heart rhythm and/or rapid rate.
These usually improve with oxygen, or preferably HBOT. Mitral valve prolapse is common in toxic
injury patients of the author as an autonomic neuropathy, and should improve
with HBOT.
Other
disturbances in patients chronically ill from exposure to petrochemical
compounds, combustion products, and other irritants include disturbance of
adrenal cortisol daily rhythm, energy metabolism, amino acids, detoxification
(with lower glutathione levels and increased free radicals), altered membrane
lipids, reduced secretory IgA with increased prevalence of parasites and Candida,
reduced pancreatic enzymes (using chymotrypsin as a marker), increased food
intolerances, reduced intracellular minerals, and reduction of other nutrients
such as B vitamins involved in energy metabolism and other body functions,
frequent reduction in B12 and reduced total antioxidant function (using
lymphocytes mitogenesis as an indicator of need following lipophilic toxin
exposure).
Reproductive
changes in earlier tested toxic injury patients include common lack of
ovulation in women of reproductive age and estrogen dominance in pre- and
postmenopausal women. Testosterone
deficiency is not uncommon. Melatonin
deficiency and disturbed melatonin daily rhythm is also common. Testing for abnormalities should use the
most sensitive available technology as described, and patients treated
according to test results.
For
nutritional supplementation, a helpful principle is to introduce only one
supplement at a time, beginning with very small dose levels and increasing as
tolerated. The author has typically avoided IV nutrient administration: benefit
is short-lived, and veins should be conserved for necessary IV use. The goal is
to develop a diet which helps replace deficient nutrients, avoids food
intolerances, has adequate protein and antioxidants, and is low glycemic for
adrenal disturbance and Candida control.
Due to low
body temperature, fever should be evaluated by an elevation of a degree or more
over the patient's usual temperature and the patient's sensation of feeling
feverish at the time of temperature elevation.
Before use of antibiotics, WBC differential is recommended. WBC total runs low in toxic injury patients
and is often not elevated with infection, but increased percent of
polymorphonuclear cells suggests likely bacterial infection. Due to the lower rate of medication
clearance in these patients, antibiotics can be used at about two-thirds of
usual dose, and other pharmaceuticals at about half dose, or even less for
symptom reducing medications.
Due to
cognitive disturbance, medical providers should give patients written
information whenever possible, in addition to answering questions (with a
spouse or friend present if possible to assist in recall, etc.). Initial evaluation can require two hours or
more, and follow-up often requires one to two hours. However, the treatability of toxic injury is important and can be
scientific and test-based. No longer do medical providers need to tell toxic
injury patients that they can’t be treated or will not get better. Early detection of warning symptoms and
awareness by medical providers, managers, and the general public can often help
prevent disability by early removal from exposure and correcting exposure to
below symptomatic levels.
[1] GE.
Ziem, J McTamney, “Profile of patients
with chemical injury and sensitivity”, Environ Health Perspect: 417-436, 1997.
[2] TJ.
Callender, et al., “Olfactory intolerance and dynamic neurophysiological
abnormalities in patients with toxic encephalopathy”, Advances in the
BioSciences 93: 611 - 619, 1994.
[3] M.J.
Hodgson, et al., “Encephalopathy and vestibulopathy following short-term
hydrocarbon exposure”, J Occup Med 31: 51-54, 1989.
[4] S. M.
Antelman, “Time dependent sensitization in animals”, Toxicol. Ind. Health,
10:335-342, 1994.
[5] I. R. Bell,
“Neuropsychiatric aspects of sensitivity to low-level Chemicals: A neural
sensitization model”, Toxicol. Ind. Health, 10:277-312, 1994.
[6] L.A. Morrow, et
al., “Alternations in cognitive and psychological functioning after organic
solvent exposure”, J. Occup Med, 32:444-450, 1990.
[7] S.C. Foo, et
al., “Chronic neurobehavioral effects of toluene”, J. Ind. Med,
47:480-44, 1990.
[8] P. Orbaek ,
M. Lindgren, “Prospective clinical and psychometric investigation of patients
with chronic toxic encephalopathy
induced by solvents”, Scand J Work Environ Health, 14:37-44, 1988.
[9] B.P. Stollery
, M.L.H. Flindt, “Memory sequelae of solvent intoxication”,Scand J Work
Environ Health, 14:45-48, 1988.
[10] C. Edling, et
al., “Long-term follow-up of workers exposed to solvents”, British J
Indust Med 47:75-82, 1990.
[11] H. Rasmussen, et
al., “Risk of encephalopathia amongst retired solvent-exposed workers”, J.
Occup Med,27:581-565, 1985.
[12] P. Bruhn, et
al., “Prognosis in chronic toxic
encephalopathy: A two year follow-up study in 26 house painters with
occupational encephalopathy”, Acta
Neurol. Scand, 64: 259-272, 1981.
[13] P. Gregersen, et
al., “Chronic toxic encephalopathy
in solvent-exposed painters in Denmark 1976-1980: Clinical cases and social
consequences after a 5-year follow-up”, Am J Ind Med 11: 399-417, 1987.
[14] K.H. Kilburn,
Editor, Chemical Brain Injury, Van Nostrand Reinhold 1998.
[15] CE Fincher, et
al., “Comparison of single photon emission
computed tomography findings in cases of
healthy adults and solvent-exposed adults”, Am J. Ind Med 31: 4-14,
1997.
[16] J.L.
O’Donoghue, Editor, Neurotoxicity of Industrial and Commercial Chemicals,
Vol.I and II, CRC Press, 1985.
[17] P.
Arlien-Soborg, Editor, Solvent Neurotoxicity, CRC Press, 1992.
[18] A. Englund, K.
Ringen, M. Mehlman, Editors, Advances in Modern Environmental Toxicology,
Vol. II, Occupational Health
Hazards of Solvents, Princeton
Scientific Publishers, 1982.
[19] L Molhave, et
al. "Human reactions to low concentrations of volatile organic
compounds", Env Int 12:167-175, 1986.
[20] S. Elofsson,
etal., “Exposure to organic solvents”, Scand J Work Envorn Health,
6:239-273, 1980.
[21] A.M.
Seppalainen, et al.,
“Neurophysiological effects of long-term exposure to a mixture of
organic solvents”, Scand. J. Work Environ Health, 4: 304-314, 1978.
[22] E.J. Jonkman,
et al., “Electroencephalographic
studies in workers exposed to solvents or pesticides”, Electroencephalogr
Clin Neurophysiol, 82: 439-444, 1992.
[23] A.I. Bokina,
et al., “Investigation of the mechanism
of action of atmospheric pollutants on the central nervous system and
compararative evaluation of methods of study”, Environ. Health Perspect,
13: 37-42, 1976.
[24] P. Gregersen,
“Neurotoxic Effects of Organic Solvents in Exposed Workers: Two Controlled
Follow-up Studies After 5.5 and 10.6 Years”, Am J. Ind Med, 14: 681-701,
1988.
[25] L.M. Odkvist,
et al., “Otoneurologic disturbances caused by solvent pollution”, Otolaryngolgy-Head
and Neck Surg., 106: 687-692, 1992.
[26] L. Morrow, et
al., “A distinct pattern of personality
disturbance following exposure to mixtures of organic solvents”, J Occup Med, 31: 743-746, 1989.
[27] S.M. Gospe and
M.J. Calaban, “Central nervous system distribution of inhaled toluene”, Fundam
Appl Toxicol, 11:540-545, 1988.
[28] Principals of
neurotoxicity risk assessment, US EPA, Federal Register August 17, 1994.
[29] L. Hastings
and J.E. Evans, “Olfactory primary neurons as a route of entry for toxic agents
into the central nervous system”, J. of Neurotoxicology 12:707-714,
1991.
[30] GE Ziem,
“Profile of patients with chemical injury and sensitivity”, Int J Toxicol 18:401-409, 1999.
[31] H. Savolainan,
“Some aspects of the mechanisms by which industrial solvents produce neurotoxic
effects”, Chem. Biol. Interactions, 18:1-10, 1977.
[32] T. J.
Callender, et al., “Three-dimensional
brain and metabolic imaging in patients with toxic encephalopathy”, Environ.
Res 60: 295-319, 1993.
[33] T.J.
Callender, et al., “Evaluation of
chronic neurological sequelae after acute pesticide exposure using SPECT brain scans”. J. Toxicol. Envirion. Health
41:275-284, 1995.
[34] G. Heuser, et
al., “Neurospect findings in patients
exposed to neurotoxic chemicals”, Toxicol
Ind Health, 10: 561-571, 1994.
[35] H.M. Kipen, et
al., “Asthma experience in an occupational medicine clinic. Low dose reactive airway dysfunction
syndrome”, J. Occup. Med. 36:1133-1137, 1994.
[36] S.M. Brooks,
et al., “Reactive airway dysfunction syndrome”, J. Occup. Med. 27,
473-476, 1985.
[37] S.M. Tarbo
and I. Broder, “Irritant-induced occupational asthma”, Chest 96:297-300,
1989.
[38] WJ Meggs, “RADS and RUDS-The toxic induction of
asthma and rhinitis”, Clinic Toxic 32(5): 487-501, 1994.
[39] WJ Meggs et
al., “Nasal pathology and ultrastructure in patients with chronic airway
inflammation (RADS and RUDS) following an irritant exposure”, Clinic Toxic
34(4): 383-396, 1996.
[40] W.J. Meggs,
“Neurogenic inflammation and sensitivity to environmental chemicals”, Enviorn.
Health Perspect, 101:234-237, 1993.
[41] A
Hempel-Jorgensen et al., “Sensory eye irritation in humans exposed to
mixtures of volatile organic compounds”, Archiv Environ Health 54:
416-424, 1999.
[42] N.H. Proctor
and J.P. Hughes, Editors, Chemical Hazards of the Workplace, J.B.
Lippincott, Philadelphia, PA.
[43] R.E. Lenga,
Editor, The Sigma-Aldrich Library of Chemical Safety Data, pp. 1-3636,
Sigma Aldrich Corporation, Milwaukee, WI.
[44] HK Hudnell etal,.
“Exposure of humans to volatile organic mixture. II. sensory”, Archiv
Environ Health 47:31-38, 1992.
[45] JE
Cometto-Muniz et al., “Agonist sensory effects of airborne chemicals in
mixtures: odor, nasal prengency and eye irritation”, Percept Psychophysiol
59: 665-674, 1997.
[46] WJ Meggs,
“Health effects of indoor air pollution”, NC. Med J 53(7): 354-358,
1992.
[47] L. Perfetti et
al., “Changes in IgE-mediated
allergy to ubiquitous inhalants after removal from or diminution of exposure to the agent causing occupational
asthma”, Clin and Exp Allergy 28: 66-73, 1998.
[48] S.M. Brooks,
et al., “Reactive airway dysfunction syndrome”, J. Occup. Med. 27,
473-476, 1985.
[49] S.M. Tarbo and
I. Broder, “Irritant-induced occupational asthma”, Chest 96:297-300,
1989.
[50] HK Hudnell et
al., “Time course of odor and irritation effects in humans exposed to a
mixture of 22 volatile organic compounds”, Proc Indoor Air ‘93 1:
567-572,1993.
[51] C Shim, MH
Williams Jr., “Effect of odors in asthma”, Am J Med 80: 18-22, 1986.
[52] C. Baldwin et
al., “Odor sensitivity and respiratory complaint profiles in a
community-based sample with asthma, hay fever, and chemical odor intolerance”, Toxicol
Ind Health 15: 403-409, 1999.
[53] E Millqvist et
al., “Sensory hyperreactivity-a possible mechanism underlying cough and
esthma-like symptoms”, Allergy 53: 1208-1212, 1998.
[54] E Millqvist et
al., “Provocations with perfume in the eyes induce airway symptoms in
patients with sensory hyperreactivity”, Allergy 54: 495-499, 1999.
[55] CD. Clayson,
MO. Amdur, J. Doull, Editors, Casarett and Doull's Toxicology: The Basic
Science of Poisons, MacMillan Publishing Co., New York, NY.
[56] AL. Davidoff,
PM. Keyl, “Symptoms and health status in individuals with multiple chemical
sensitivity syndrome from four reported
sensitizing exposures and a general population comparison group”, Archiv
Environ Health 51:201-213, 1996.
[57] HM. Kipen, et
al. “Measuring chemical sensitivity prevalence: A questionnaire for
population studies”, Am J Public Health 85: 574-577, 1995.
[58] MB Lax, PK Henneberger,
“Patients with Multiple Chemical Sensitivities in an Occupational Health
Clinic: Presentation and Followup”, Archiv. Env. Health 50:425-431,
1995.
[59] “Treatment
efficacy, a survey of 305 MCS patients,”
The CFIDS Chronicle,
Winter 1996, pp. 52-53.
[60] T.H. Davis,
L.A. Jason, and M.A. Banghart, “The Effect of Housing on Individuals With
Multiple Chemical Sensitivities”, Arch. Env. Health, 50:425-431, 1995.
[61] C S. Miller,
“Multiple Chemical Sensitivity Syndrome”, J. Occup. Env. Med., 37:13-23, 1995.
[62] SA Roach
and SM Rappaport, “But they are not
thresholds: A critical analysis of the documentation of threshold limit
values”, Am J Indust Med 17:727-753, 1990.
[63] G Ziem and B
Castleman, “Threshold limit values:Historical perspectives and current
practice”, J Occup Med 31:910-918, 1989.
[64] Beyond
Pesticides, 701 E St. SE, Washington, DC.
[65] JL McCarman, Weeds
and Why They Grow, Sand Lake, MI, 1994.
[66] N Gorman,
Editor, Less-Toxic Alternatives
, Optimun Publishing Company, DeKalb, TX. 1997.
[67] IR Bell, et
al., “Self-reported illness from chemical odors in young adults without
clinical syndromes or occupational exposures”, Archiv Environ Health 48:
6-13, 1993.
[68] IR Bell, et
al., “Possible time-dependendent
sensitization to xenobiotics: self-reported illness from chemical odors, foods,
and opiate drugs in an older adult poulation”, Archiv Environ Health 48 315-327, 1993.
[69] Residential
Air Cleaning Devices: A Summary of Available Information. United States
Environmental Protection Agency 400-1-90-002.
[69] Matrix
International, 24663 Clover Rd. Willits, CA. 95490, (707-459-3832).
[70] Z. Tretjak etal,
“PCB reduction and clinical improvement by detoxification”, Human Experiment
Tox, 9:235-44, 1990.
[71] D. Schnare
and M. Shields, “Body burden reduction of PBS’s, PBB’s and chlorinated
pesticides in human subjects”, Ambio 13:378-80, 1954.
[72] D. Root and
G. Lionelli, “Excretion of a lipophilic toxicant through the sebaceous glands”,
International Agency for Research on Cancer Symposium, June 24-28,
1985.
[73] D.W. Schnare,
etal, “Evaluation of a detoxification regiment for fat stored xenobiotics”, Medical
Hypotheses 9:265-82, 1982.
[74] Z. Tretjak, etal,
“Xenobiotic reduction and clinical improvements in capacitor workers”, J. Environ.
Sci Health
[75] Hanlon vs.
Arizona Chemical Corp., State of Florida Department of Labor and Employment
Security.
[76] BS Levy and
D. H. Wegman, Occupational health: recognizing and preventing work-related
disease, Little, Brown and Company, Boston, Massachusetts, 1988.
[77] S.
Hagstadius, et al., “Regional cerebral blood flow at the time of
diagnosis of chronic toxic encephalopathy induced by organic-solvent exposure
and after the cessation of exposure”, Scan J Work Environ Health
15:130-135, 1989.
[78] T. J.
Callender, et al., “Three-dimensional
brain and metabolic imaging in patients with toxic encephalopathy”, Environ.
Res 60: 295-319, 1993.
[79] T.J.
Callender, et al., “Evaluation of
chronic neurological sequelae after acute pesticide exposure using SPECT brain
scans”. J. Toxicol. Envirion. Health
41:275-284, 1995.
[80] G. Heuser, et
al., “Neurospect findings in patients
exposed to neurotoxic chemicals”, Toxicology
Industrial Health, 10: 561-571, 1994.
[81] CE Fincher,
et al., “Comparison of single photon emission computed tomography findings in
cases of healthy adults and solvent-exposed adults”, Amer J. Ind Med 31:
4-14, 1997.
[82] K.K. Jain, Textbook
of Hyperbaric Medicine, Hogrefe and Huber Pub Co., Seattle, WA, 1999.
[83] G.E. Ziem,
clinical test results on dozens of chronically ill toxic injury patients in Dr.
Ziem’s medical practice.
[84] E.P.
Kindwell and H.T. Whelan, editors, Hyperbaric Medicine Practice, Best
Publishing Co., 1999.
[85] G.E. Ziem,
“Profile of patients with Chemical injury and sensitivity, Part II”, Int. J.
Toxicol., 18:401-409, 1999.
[86] Mixing
chamber obtainable through the Environmental Health Foundation, Dallas,
TX.
[87] I. Ezeonu, et
al., “Fungal production of volatiles during growth on fiberglass”, Appl.
Environ. Microb., 60:4172-4173, 1994.
[88] C. Bayer,
“Volatile emissions from fungi”, Engineering Solutions to Indoor Air Quality
Problems, Environmental Protection Agency Symposium, July 22-24, 1995,
published by the Air and Waste Management
Association, Pittsburgh, PA.
[89] C. Bayer, et
al., “Production of volatile emissions by fungi”, Practical Engineering for Indoor Air Quality, IAQ 95, Symposium of October 22-24, 1995,
Denver, CO, sponsored by U.S. Environmental Protection Agency, US Department of Energy and American Society
of Heating, Refrigerating, and Air Conditioning Engineers, Inc.
[90] D Ahearn,
“Fungal colonization of air filters and insulation in a multi-story office
building: Production of volatile organics”, Curr Microbiol 35: 305-308,
1997.
[91] TW Robinson, et
al., “Generation of glycoladehyde from guinea pig air way epithelial
monolayers exposed to nitrogen dioxide and its effects on sodium pump
activity”, Environ Health Perspect 104:852-856, 1996.
[92] Kahn, JP,
etal, “Salivary cortisol: a practical
method for evaluation of adrenal function”, Biol Psychiatry 23: 35-349,
1988.
[93] Bolufer, P.
etal, “Salivary corticosteroids in the study of adrenal function”, Clinica
Chemica Acta 183: 217-226, 1989.
[94] MH Laudat,
etal, “Salivary cortisol measurement: a
practical approach to assess pituitary-adrenal function”, J Clin Endocrinol
Metab 66: 343, 1988.
[95] E Bernton,
etal., “Adaptation to chronic stress in miliary trainees”, Ann NY Acad Sci
774:217-231, 1995.
[96] The author’s patients
have achieved significant adrenal function improvement with these measures.
[97] RK. Murray, D
J. Granner, PA. Mayes, VW. Rodwell, editors, Harper's Biochemistry,
Appleton and Lange, Norwalk CT.
[98] B Levine,
Editor, Environmental Nutrition,
Hingepin, Vason Island, WA.,
1999.
[99] A Spector, “
Review: oxidative stress and disease”, J Ocul Pharmocol Thera
16:193-201, 2000.
[100] M Avirum,
“Review of human studies of oxidative damage and antioxidant protection related
to cardiovascular diseases”, Free Radic Res 33: Supp S85-97, 2000.
[101] RW Alexander,
“Hypertension and the pathogenesis of arteriosclerosis. Oxidative stress and
the mediation of arterial inflammatory
response”, Hypertension 25:155-161, 1995.
[102] CB Ambrosone,
“Oxidants and antioxidants in breast cancer”, Antioxid Redox Signal
2:903-917, 2000.
[103] CF Babbs,
“Free radicals and the etiology of colon cancer”, Free Radic Biol Med 8:191-200, 1990.
[104] IL Chapple,
“Reactive oxygen speciec in inflammatory disease”, J Clin Periodontol
24:287-296, 1997.
[105] S Toyokuni,
“Reactive oxygen species-induced molecular damaged and its application in
pathology”, Pathol Int
49:91-102, 1999.
[106] JA Knight,
“The biochemistry of aging”, Adv Clin Chem 35:1-62, 2000.
[107] L. O. Simpson, New Zealand Medical Journal 106:
104-107, 1993
[108] Great
Smokies Diagnostic Laboratory, Asheville, N.C.
[109] MetaMetrix
Laboratory, Norcross, G.A.
[110] M. C. Linder,
Nutritional Biochemistry and Metabolism Appleton and Lange, Norwalk CT,
1991.
[111] U. Erasmus, Fats
That Heal, Fats That Kill Alive Books, Burnaby, British Columbia, Canada,
1993.
[112] M Boosalis, et
al., “Impaired handling of orally administered zinc in pancreatic
insufficieny”, Am J Clin Nutr 37: 268-271, 1983.
[113] P. Borner,
“Functional intracellular analysis of nutritional and antioxidant status”, Journal
of the American Neutraceutical Association 4: 27-41, 2001.
[114] JE Pizzorno
and MT Murray, editors, Textbook of Natural Medicine, Churchill
Livingstone on, New York, NY.
[115] K. L. Becker,
editor, Principals and Practice of Endocrinology and Metabolism, J. B.
Lippincott Company, Philadelphia, PA, 1995.